{
    "medicine_id": "f3a524b828b330a4986ebe6c093ec1c6bcb6d9b1",
    "platform_id": "DB00751",
    "metadata": {
        "name": "Elestat 0 5 mg 1mL Solution drops",
        "composition": "0 5 mg 1mL Epinastine",
        "clinical_particulars": {
            "therapeutic_indications": "For the prevention of itching associated with allergic conjunctivitis",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Epinastine is an antihistamine and an inhibitor of histamine release from the mast cell for topical administration to the eyes Epinastine is indicated for the prevention of itching associated with allergic conjunctivitis Epinastine is a topically active direct H sub 1 sub receptor antagonist and an inhibitor of the release of histamine from the mast cell Epinastine is selective for the histamine H sub 1 sub receptor and has affinity for the histamine H2 receptor Epinastine also possesses affinity for the a1 a2 and 5 HT sub 2 sub receptors Epinastine does not penetrate the blood brain barrier and therefore is not expected to induce side effects of the central nervous system",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00921",
                        "description": "Buprenorphine may increase the central nervous system depressant CNS depressant activities of Epinastine"
                    },
                    {
                        "drugbank-id": "DB00366",
                        "description": "Doxylamine may increase the central nervous system depressant CNS depressant activities of Epinastine"
                    },
                    {
                        "drugbank-id": "DB00470",
                        "description": "Dronabinol may increase the central nervous system depressant CNS depressant activities of Epinastine"
                    },
                    {
                        "drugbank-id": "DB00450",
                        "description": "Droperidol may increase the central nervous system depressant CNS depressant activities of Epinastine"
                    },
                    {
                        "drugbank-id": "DB00956",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Hydrocodone"
                    },
                    {
                        "drugbank-id": "DB00653",
                        "description": "The therapeutic efficacy of Epinastine can be increased when used in combination with Magnesium sulfate"
                    },
                    {
                        "drugbank-id": "DB01403",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Methotrimeprazine"
                    },
                    {
                        "drugbank-id": "DB00765",
                        "description": "Epinastine may increase the sedative activities of Metyrosine"
                    },
                    {
                        "drugbank-id": "DB01017",
                        "description": "Minocycline may increase the central nervous system depressant CNS depressant activities of Epinastine"
                    },
                    {
                        "drugbank-id": "DB00370",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Mirtazapine"
                    },
                    {
                        "drugbank-id": "DB00486",
                        "description": "Nabilone may increase the central nervous system depressant CNS depressant activities of Epinastine"
                    },
                    {
                        "drugbank-id": "DB01173",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Orphenadrine"
                    },
                    {
                        "drugbank-id": "DB09117",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Paraldehyde"
                    },
                    {
                        "drugbank-id": "DB08883",
                        "description": "Perampanel may increase the central nervous system depressant CNS depressant activities of Epinastine"
                    },
                    {
                        "drugbank-id": "DB00413",
                        "description": "Epinastine may increase the sedative activities of Pramipexole"
                    },
                    {
                        "drugbank-id": "DB00268",
                        "description": "Epinastine may increase the sedative activities of Ropinirole"
                    },
                    {
                        "drugbank-id": "DB05271",
                        "description": "Epinastine may increase the sedative activities of Rotigotine"
                    },
                    {
                        "drugbank-id": "DB06201",
                        "description": "The risk or severity of adverse effects can be increased when Rufinamide is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB09072",
                        "description": "Sodium oxybate may increase the central nervous system depressant CNS depressant activities of Epinastine"
                    },
                    {
                        "drugbank-id": "DB09034",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Suvorexant"
                    },
                    {
                        "drugbank-id": "DB06204",
                        "description": "Tapentadol may increase the central nervous system depressant CNS depressant activities of Epinastine"
                    },
                    {
                        "drugbank-id": "DB01041",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Thalidomide"
                    },
                    {
                        "drugbank-id": "DB00425",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Zolpidem"
                    },
                    {
                        "drugbank-id": "DB00895",
                        "description": "Epinastine may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent"
                    },
                    {
                        "drugbank-id": "DB06698",
                        "description": "The therapeutic efficacy of Betahistine can be decreased when used in combination with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00070",
                        "description": "The therapeutic efficacy of Hyaluronidase ovine can be decreased when used in combination with Epinastine"
                    },
                    {
                        "drugbank-id": "DB06205",
                        "description": "The therapeutic efficacy of Hyaluronidase human recombinant can be decreased when used in combination with Epinastine"
                    },
                    {
                        "drugbank-id": "DB14740",
                        "description": "The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00333",
                        "description": "The risk or severity of adverse effects can be increased when Methadone is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00289",
                        "description": "The metabolism of Atomoxetine can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB01072",
                        "description": "Epinastine can cause a decrease in the absorption of Atazanavir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB06616",
                        "description": "Epinastine can cause a decrease in the absorption of Bosutinib resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01066",
                        "description": "Epinastine can cause a decrease in the absorption of Cefditoren resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01416",
                        "description": "Epinastine can cause a decrease in the absorption of Cefpodoxime resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01112",
                        "description": "Epinastine can cause a decrease in the absorption of Cefuroxime resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB08912",
                        "description": "Dabrafenib can cause a decrease in the absorption of Epinastine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01254",
                        "description": "Epinastine can cause a decrease in the absorption of Dasatinib resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00705",
                        "description": "Delavirdine can cause a decrease in the absorption of Epinastine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB06701",
                        "description": "The therapeutic efficacy of Dexmethylphenidate can be decreased when used in combination with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00530",
                        "description": "Erlotinib can cause a decrease in the absorption of Epinastine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00701",
                        "description": "Amprenavir can cause a decrease in the absorption of Epinastine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01319",
                        "description": "Epinastine can cause a decrease in the absorption of Fosamprenavir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00317",
                        "description": "Gefitinib can cause a decrease in the absorption of Epinastine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00224",
                        "description": "Epinastine can cause a decrease in the absorption of Indinavir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01167",
                        "description": "Itraconazole can cause a decrease in the absorption of Epinastine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09027",
                        "description": "Epinastine can cause a decrease in the absorption of Ledipasvir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00422",
                        "description": "The therapeutic efficacy of Methylphenidate can be decreased when used in combination with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00220",
                        "description": "Nelfinavir can cause a decrease in the absorption of Epinastine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB04868",
                        "description": "Nilotinib can cause a decrease in the absorption of Epinastine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB06589",
                        "description": "The therapeutic efficacy of Epinastine can be decreased when used in combination with Pazopanib"
                    },
                    {
                        "drugbank-id": "DB08864",
                        "description": "Rilpivirine can cause a decrease in the absorption of Epinastine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00884",
                        "description": "Epinastine can cause an increase in the absorption of Risedronic acid resulting in an increased serum concentration and potentially a worsening of adverse effects"
                    },
                    {
                        "drugbank-id": "DB01232",
                        "description": "Saquinavir can cause an increase in the absorption of Epinastine resulting in an increased serum concentration and potentially a worsening of adverse effects"
                    },
                    {
                        "drugbank-id": "DB00266",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Dicoumarol"
                    },
                    {
                        "drugbank-id": "DB00498",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Phenindione"
                    },
                    {
                        "drugbank-id": "DB00682",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Warfarin"
                    },
                    {
                        "drugbank-id": "DB00946",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Phenprocoumon"
                    },
                    {
                        "drugbank-id": "DB01418",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Acenocoumarol"
                    },
                    {
                        "drugbank-id": "DB03410",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with 4 hydroxycoumarin"
                    },
                    {
                        "drugbank-id": "DB04665",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Coumarin"
                    },
                    {
                        "drugbank-id": "DB08496",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with R warfarin"
                    },
                    {
                        "drugbank-id": "DB08794",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Ethyl biscoumacetate"
                    },
                    {
                        "drugbank-id": "DB13136",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Fluindione"
                    },
                    {
                        "drugbank-id": "DB13275",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Clorindione"
                    },
                    {
                        "drugbank-id": "DB13347",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Diphenadione"
                    },
                    {
                        "drugbank-id": "DB13451",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Tioclomarol"
                    },
                    {
                        "drugbank-id": "DB14055",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with S Warfarin"
                    },
                    {
                        "drugbank-id": "DB00244",
                        "description": "The therapeutic efficacy of Mesalazine can be decreased when used in combination with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00898",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Ethanol"
                    },
                    {
                        "drugbank-id": "DB00972",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Azelastine"
                    },
                    {
                        "drugbank-id": "DB00484",
                        "description": "Brimonidine may increase the central nervous system depressant CNS depressant activities of Epinastine"
                    },
                    {
                        "drugbank-id": "DB01104",
                        "description": "The risk or severity of adverse effects can be increased when Sertraline is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB01149",
                        "description": "The risk or severity of adverse effects can be increased when Nefazodone is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB06700",
                        "description": "The risk or severity of adverse effects can be increased when Desvenlafaxine is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00215",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Citalopram"
                    },
                    {
                        "drugbank-id": "DB01105",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Sibutramine"
                    },
                    {
                        "drugbank-id": "DB04832",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Zimelidine"
                    },
                    {
                        "drugbank-id": "DB04884",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Dapoxetine"
                    },
                    {
                        "drugbank-id": "DB04896",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Milnacipran"
                    },
                    {
                        "drugbank-id": "DB06731",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Seproxetine"
                    },
                    {
                        "drugbank-id": "DB08918",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Levomilnacipran"
                    },
                    {
                        "drugbank-id": "DB08953",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Indalpine"
                    },
                    {
                        "drugbank-id": "DB13233",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Alaproclate"
                    },
                    {
                        "drugbank-id": "DB01255",
                        "description": "Lisdexamfetamine may decrease the sedative and stimulatory activities of Epinastine"
                    },
                    {
                        "drugbank-id": "DB00182",
                        "description": "Amphetamine may decrease the sedative and stimulatory activities of Epinastine"
                    },
                    {
                        "drugbank-id": "DB00191",
                        "description": "Phentermine may decrease the sedative and stimulatory activities of Epinastine"
                    },
                    {
                        "drugbank-id": "DB00852",
                        "description": "Pseudoephedrine may decrease the sedative and stimulatory activities of Epinastine"
                    },
                    {
                        "drugbank-id": "DB00865",
                        "description": "Benzphetamine may decrease the sedative and stimulatory activities of Epinastine"
                    },
                    {
                        "drugbank-id": "DB00937",
                        "description": "Diethylpropion may decrease the sedative and stimulatory activities of Epinastine"
                    },
                    {
                        "drugbank-id": "DB01365",
                        "description": "Mephentermine may decrease the sedative and stimulatory activities of Epinastine"
                    },
                    {
                        "drugbank-id": "DB01442",
                        "description": "MMDA may decrease the sedative and stimulatory activities of Epinastine"
                    },
                    {
                        "drugbank-id": "DB01454",
                        "description": "Midomafetamine may decrease the sedative and stimulatory activities of Epinastine"
                    },
                    {
                        "drugbank-id": "DB01467",
                        "description": "2 5 Dimethoxy 4 ethylamphetamine may decrease the sedative and stimulatory activities of Epinastine"
                    },
                    {
                        "drugbank-id": "DB01484",
                        "description": "4 Bromo 2 5 dimethoxyamphetamine may decrease the sedative and stimulatory activities of Epinastine"
                    },
                    {
                        "drugbank-id": "DB01509",
                        "description": "Tenamfetamine may decrease the sedative and stimulatory activities of Epinastine"
                    },
                    {
                        "drugbank-id": "DB01556",
                        "description": "Chlorphentermine may decrease the sedative and stimulatory activities of Epinastine"
                    },
                    {
                        "drugbank-id": "DB01566",
                        "description": "Methylenedioxyethamphetamine may decrease the sedative and stimulatory activities of Epinastine"
                    },
                    {
                        "drugbank-id": "DB01576",
                        "description": "Dextroamphetamine may decrease the sedative and stimulatory activities of Epinastine"
                    },
                    {
                        "drugbank-id": "DB01577",
                        "description": "Metamfetamine may decrease the sedative and stimulatory activities of Epinastine"
                    },
                    {
                        "drugbank-id": "DB09480",
                        "description": "Iofetamine I 123 may decrease the sedative and stimulatory activities of Epinastine"
                    },
                    {
                        "drugbank-id": "DB12080",
                        "description": "Ritobegron may decrease the sedative and stimulatory activities of Epinastine"
                    },
                    {
                        "drugbank-id": "DB13108",
                        "description": "Mephedrone may decrease the sedative and stimulatory activities of Epinastine"
                    },
                    {
                        "drugbank-id": "DB13624",
                        "description": "Methoxyphenamine may decrease the sedative and stimulatory activities of Epinastine"
                    },
                    {
                        "drugbank-id": "DB13703",
                        "description": "Gepefrine may decrease the sedative and stimulatory activities of Epinastine"
                    },
                    {
                        "drugbank-id": "DB13940",
                        "description": "2 5 Dimethoxy 4 ethylthioamphetamine may decrease the sedative and stimulatory activities of Epinastine"
                    },
                    {
                        "drugbank-id": "DB00847",
                        "description": "Epinastine can cause an increase in the absorption of Cysteamine resulting in an increased serum concentration and potentially a worsening of adverse effects"
                    },
                    {
                        "drugbank-id": "DB01026",
                        "description": "Ketoconazole can cause a decrease in the absorption of Epinastine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00209",
                        "description": "Trospium may increase the central nervous system depressant CNS depressant activities of Epinastine"
                    },
                    {
                        "drugbank-id": "DB00219",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Oxyphenonium"
                    },
                    {
                        "drugbank-id": "DB00245",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Benzatropine"
                    },
                    {
                        "drugbank-id": "DB00280",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Disopyramide"
                    },
                    {
                        "drugbank-id": "DB00332",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Ipratropium"
                    },
                    {
                        "drugbank-id": "DB00334",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Olanzapine"
                    },
                    {
                        "drugbank-id": "DB00340",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Metixene"
                    },
                    {
                        "drugbank-id": "DB00354",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Buclizine"
                    },
                    {
                        "drugbank-id": "DB00376",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Trihexyphenidyl"
                    },
                    {
                        "drugbank-id": "DB00383",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Oxyphencyclimine"
                    },
                    {
                        "drugbank-id": "DB00387",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Procyclidine"
                    },
                    {
                        "drugbank-id": "DB00392",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Profenamine"
                    },
                    {
                        "drugbank-id": "DB00420",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Promazine"
                    },
                    {
                        "drugbank-id": "DB00424",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00434",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Cyproheptadine"
                    },
                    {
                        "drugbank-id": "DB00462",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Methscopolamine bromide"
                    },
                    {
                        "drugbank-id": "DB00483",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Gallamine triethiodide"
                    },
                    {
                        "drugbank-id": "DB00505",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Tridihexethyl"
                    },
                    {
                        "drugbank-id": "DB00508",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Triflupromazine"
                    },
                    {
                        "drugbank-id": "DB00517",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Anisotropine methylbromide"
                    },
                    {
                        "drugbank-id": "DB00555",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Lamotrigine"
                    },
                    {
                        "drugbank-id": "DB00572",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Atropine"
                    },
                    {
                        "drugbank-id": "DB00670",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Pirenzepine"
                    },
                    {
                        "drugbank-id": "DB00725",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Homatropine methylbromide"
                    },
                    {
                        "drugbank-id": "DB00728",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Rocuronium"
                    },
                    {
                        "drugbank-id": "DB00747",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Scopolamine"
                    },
                    {
                        "drugbank-id": "DB00767",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Benzquinamide"
                    },
                    {
                        "drugbank-id": "DB00771",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Clidinium"
                    },
                    {
                        "drugbank-id": "DB00777",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Propiomazine"
                    },
                    {
                        "drugbank-id": "DB00782",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Propantheline"
                    },
                    {
                        "drugbank-id": "DB00804",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Dicyclomine"
                    },
                    {
                        "drugbank-id": "DB00810",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Biperiden"
                    },
                    {
                        "drugbank-id": "DB00835",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Brompheniramine"
                    },
                    {
                        "drugbank-id": "DB00875",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Flupentixol"
                    },
                    {
                        "drugbank-id": "DB00907",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Cocaine"
                    },
                    {
                        "drugbank-id": "DB00934",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00940",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Methantheline"
                    },
                    {
                        "drugbank-id": "DB00942",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Cycrimine"
                    },
                    {
                        "drugbank-id": "DB00986",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Glycopyrronium"
                    },
                    {
                        "drugbank-id": "DB01036",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Tolterodine"
                    },
                    {
                        "drugbank-id": "DB01062",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Oxybutynin"
                    },
                    {
                        "drugbank-id": "DB01069",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Promethazine"
                    },
                    {
                        "drugbank-id": "DB01075",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Diphenhydramine"
                    },
                    {
                        "drugbank-id": "DB01135",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Doxacurium"
                    },
                    {
                        "drugbank-id": "DB01142",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Doxepin"
                    },
                    {
                        "drugbank-id": "DB01148",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Flavoxate"
                    },
                    {
                        "drugbank-id": "DB01224",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Quetiapine"
                    },
                    {
                        "drugbank-id": "DB01226",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Mivacurium"
                    },
                    {
                        "drugbank-id": "DB01231",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Diphenidol"
                    },
                    {
                        "drugbank-id": "DB01239",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Chlorprothixene"
                    },
                    {
                        "drugbank-id": "DB01336",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Metocurine"
                    },
                    {
                        "drugbank-id": "DB01337",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Pancuronium"
                    },
                    {
                        "drugbank-id": "DB01338",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Pipecuronium"
                    },
                    {
                        "drugbank-id": "DB01409",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Tiotropium"
                    },
                    {
                        "drugbank-id": "DB01591",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Solifenacin"
                    },
                    {
                        "drugbank-id": "DB01625",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Isopropamide"
                    },
                    {
                        "drugbank-id": "DB04834",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB04843",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Mepenzolate"
                    },
                    {
                        "drugbank-id": "DB06153",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Pizotifen"
                    },
                    {
                        "drugbank-id": "DB06702",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Fesoterodine"
                    },
                    {
                        "drugbank-id": "DB06787",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Hexocyclium"
                    },
                    {
                        "drugbank-id": "DB08801",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Dimetindene"
                    },
                    {
                        "drugbank-id": "DB08897",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Aclidinium"
                    },
                    {
                        "drugbank-id": "DB08997",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Dexetimide"
                    },
                    {
                        "drugbank-id": "DB09023",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Benactyzine"
                    },
                    {
                        "drugbank-id": "DB09076",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Umeclidinium"
                    },
                    {
                        "drugbank-id": "DB09089",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Trimebutine"
                    },
                    {
                        "drugbank-id": "DB09262",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Imidafenacin"
                    },
                    {
                        "drugbank-id": "DB09300",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Butylscopolamine"
                    },
                    {
                        "drugbank-id": "DB11235",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Thonzylamine"
                    },
                    {
                        "drugbank-id": "DB11315",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Methscopolamine"
                    },
                    {
                        "drugbank-id": "DB11855",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Revefenacin"
                    },
                    {
                        "drugbank-id": "DB12086",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Oxitropium"
                    },
                    {
                        "drugbank-id": "DB12278",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Propiverine"
                    },
                    {
                        "drugbank-id": "DB12526",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Batefenterol"
                    },
                    {
                        "drugbank-id": "DB12554",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Mebeverine"
                    },
                    {
                        "drugbank-id": "DB13252",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Tropatepine"
                    },
                    {
                        "drugbank-id": "DB13254",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Prifinium"
                    },
                    {
                        "drugbank-id": "DB13351",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Piperidolate"
                    },
                    {
                        "drugbank-id": "DB13369",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Benzilone"
                    },
                    {
                        "drugbank-id": "DB13380",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Difemerine"
                    },
                    {
                        "drugbank-id": "DB13413",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Phenglutarimide"
                    },
                    {
                        "drugbank-id": "DB13448",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Mazaticol"
                    },
                    {
                        "drugbank-id": "DB13468",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Etybenzatropine"
                    },
                    {
                        "drugbank-id": "DB13500",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Otilonium"
                    },
                    {
                        "drugbank-id": "DB13505",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Emepronium"
                    },
                    {
                        "drugbank-id": "DB13507",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Poldine"
                    },
                    {
                        "drugbank-id": "DB13542",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Bevonium"
                    },
                    {
                        "drugbank-id": "DB13581",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Rociverine"
                    },
                    {
                        "drugbank-id": "DB13619",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Bornaprine"
                    },
                    {
                        "drugbank-id": "DB13636",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Etanautine"
                    },
                    {
                        "drugbank-id": "DB13666",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Tiemonium iodide"
                    },
                    {
                        "drugbank-id": "DB13678",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Dihexyverine"
                    },
                    {
                        "drugbank-id": "DB13695",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Penthienate"
                    },
                    {
                        "drugbank-id": "DB13720",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Diphemanil"
                    },
                    {
                        "drugbank-id": "DB13738",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Camylofin"
                    },
                    {
                        "drugbank-id": "DB13759",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Fenpiverinium"
                    },
                    {
                        "drugbank-id": "DB13769",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Emetonium iodide"
                    },
                    {
                        "drugbank-id": "DB13844",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Pipenzolate"
                    },
                    {
                        "drugbank-id": "DB13850",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Timepidium"
                    },
                    {
                        "drugbank-id": "DB09007",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Chlorphenoxamine"
                    },
                    {
                        "drugbank-id": "DB01198",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Zopiclone"
                    },
                    {
                        "drugbank-id": "DB00571",
                        "description": "The risk or severity of QTc prolongation can be increased when Propranolol is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00195",
                        "description": "The risk or severity of QTc prolongation can be increased when Betaxolol is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00343",
                        "description": "The risk or severity of QTc prolongation can be increased when Diltiazem is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00738",
                        "description": "The risk or severity of QTc prolongation can be increased when Pentamidine is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB08952",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Indenolol"
                    },
                    {
                        "drugbank-id": "DB11718",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Encorafenib"
                    },
                    {
                        "drugbank-id": "DB00007",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Leuprolide"
                    },
                    {
                        "drugbank-id": "DB00014",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Goserelin"
                    },
                    {
                        "drugbank-id": "DB00199",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00207",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Azithromycin"
                    },
                    {
                        "drugbank-id": "DB00218",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Moxifloxacin"
                    },
                    {
                        "drugbank-id": "DB00263",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Sulfisoxazole"
                    },
                    {
                        "drugbank-id": "DB00393",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Nimodipine"
                    },
                    {
                        "drugbank-id": "DB00526",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Oxaliplatin"
                    },
                    {
                        "drugbank-id": "DB00537",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Ciprofloxacin"
                    },
                    {
                        "drugbank-id": "DB00544",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Fluorouracil"
                    },
                    {
                        "drugbank-id": "DB00556",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Perflutren"
                    },
                    {
                        "drugbank-id": "DB00640",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Adenosine"
                    },
                    {
                        "drugbank-id": "DB00743",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Gadobenic acid"
                    },
                    {
                        "drugbank-id": "DB00779",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Nalidixic acid"
                    },
                    {
                        "drugbank-id": "DB00827",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Cinoxacin"
                    },
                    {
                        "drugbank-id": "DB00922",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00976",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Telithromycin"
                    },
                    {
                        "drugbank-id": "DB00978",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Lomefloxacin"
                    },
                    {
                        "drugbank-id": "DB01084",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Emedastine"
                    },
                    {
                        "drugbank-id": "DB01113",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Papaverine"
                    },
                    {
                        "drugbank-id": "DB01137",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Levofloxacin"
                    },
                    {
                        "drugbank-id": "DB01155",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Gemifloxacin"
                    },
                    {
                        "drugbank-id": "DB01165",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Ofloxacin"
                    },
                    {
                        "drugbank-id": "DB01211",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Clarithromycin"
                    },
                    {
                        "drugbank-id": "DB01599",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Probucol"
                    },
                    {
                        "drugbank-id": "DB02638",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Terlipressin"
                    },
                    {
                        "drugbank-id": "DB04825",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Prenylamine"
                    },
                    {
                        "drugbank-id": "DB04957",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Azimilide"
                    },
                    {
                        "drugbank-id": "DB05223",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Pracinostat"
                    },
                    {
                        "drugbank-id": "DB05488",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Technetium Tc 99m ciprofloxacin"
                    },
                    {
                        "drugbank-id": "DB06160",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Garenoxacin"
                    },
                    {
                        "drugbank-id": "DB06200",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Tedisamil"
                    },
                    {
                        "drugbank-id": "DB06334",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Tucidinostat"
                    },
                    {
                        "drugbank-id": "DB06402",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Telavancin"
                    },
                    {
                        "drugbank-id": "DB06600",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Nemonoxacin"
                    },
                    {
                        "drugbank-id": "DB06712",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Nilvadipine"
                    },
                    {
                        "drugbank-id": "DB08799",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Antazoline"
                    },
                    {
                        "drugbank-id": "DB08865",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Crizotinib"
                    },
                    {
                        "drugbank-id": "DB08903",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Bedaquiline"
                    },
                    {
                        "drugbank-id": "DB08980",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Fendiline"
                    },
                    {
                        "drugbank-id": "DB09063",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Ceritinib"
                    },
                    {
                        "drugbank-id": "DB09231",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Benidipine"
                    },
                    {
                        "drugbank-id": "DB11640",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB11830",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Mocetinostat"
                    },
                    {
                        "drugbank-id": "DB11841",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Entinostat"
                    },
                    {
                        "drugbank-id": "DB12174",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with CUDC 101"
                    },
                    {
                        "drugbank-id": "DB12286",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Simendan"
                    },
                    {
                        "drugbank-id": "DB12376",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Ricolinostat"
                    },
                    {
                        "drugbank-id": "DB12565",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Abexinostat"
                    },
                    {
                        "drugbank-id": "DB12877",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Oxatomide"
                    },
                    {
                        "drugbank-id": "DB13261",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Sitafloxacin"
                    },
                    {
                        "drugbank-id": "DB13546",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Nizofenone"
                    },
                    {
                        "drugbank-id": "DB13652",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Bunaftine"
                    },
                    {
                        "drugbank-id": "DB13653",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Lorcainide"
                    },
                    {
                        "drugbank-id": "DB14063",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Dexverapamil"
                    },
                    {
                        "drugbank-id": "DB14568",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Ivosidenib"
                    },
                    {
                        "drugbank-id": "DB00619",
                        "description": "The risk or severity of QTc prolongation can be increased when Imatinib is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB04844",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Tetrabenazine"
                    },
                    {
                        "drugbank-id": "DB12161",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Deutetrabenazine"
                    },
                    {
                        "drugbank-id": "DB01118",
                        "description": "The risk or severity of QTc prolongation can be increased when Amiodarone is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00204",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Dofetilide"
                    },
                    {
                        "drugbank-id": "DB00261",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00308",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Ibutilide"
                    },
                    {
                        "drugbank-id": "DB00365",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Grepafloxacin"
                    },
                    {
                        "drugbank-id": "DB00539",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Toremifene"
                    },
                    {
                        "drugbank-id": "DB00685",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Trovafloxacin"
                    },
                    {
                        "drugbank-id": "DB01169",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Arsenic trioxide"
                    },
                    {
                        "drugbank-id": "DB01208",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Sparfloxacin"
                    },
                    {
                        "drugbank-id": "DB01405",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Temafloxacin"
                    },
                    {
                        "drugbank-id": "DB05294",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Vandetanib"
                    },
                    {
                        "drugbank-id": "DB09083",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Ivabradine"
                    },
                    {
                        "drugbank-id": "DB11730",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Ribociclib"
                    },
                    {
                        "drugbank-id": "DB11978",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB13074",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Macimorelin"
                    },
                    {
                        "drugbank-id": "DB13725",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Terodiline"
                    },
                    {
                        "drugbank-id": "DB09238",
                        "description": "The metabolism of Epinastine can be decreased when combined with Manidipine"
                    },
                    {
                        "drugbank-id": "DB00285",
                        "description": "The metabolism of Epinastine can be decreased when combined with Venlafaxine"
                    },
                    {
                        "drugbank-id": "DB00342",
                        "description": "The metabolism of Epinastine can be decreased when combined with Terfenadine"
                    },
                    {
                        "drugbank-id": "DB00458",
                        "description": "The metabolism of Epinastine can be decreased when combined with Imipramine"
                    },
                    {
                        "drugbank-id": "DB00501",
                        "description": "The metabolism of Epinastine can be decreased when combined with Cimetidine"
                    },
                    {
                        "drugbank-id": "DB01087",
                        "description": "The metabolism of Epinastine can be decreased when combined with Primaquine"
                    },
                    {
                        "drugbank-id": "DB01151",
                        "description": "The metabolism of Epinastine can be decreased when combined with Desipramine"
                    },
                    {
                        "drugbank-id": "DB09167",
                        "description": "The metabolism of Epinastine can be decreased when combined with Dosulepin"
                    },
                    {
                        "drugbank-id": "DB00176",
                        "description": "The metabolism of Fluvoxamine can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00476",
                        "description": "The metabolism of Duloxetine can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB12693",
                        "description": "The metabolism of Ritanserin can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00363",
                        "description": "The metabolism of Clozapine can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00477",
                        "description": "The metabolism of Chlorpromazine can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00496",
                        "description": "The metabolism of Darifenacin can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00622",
                        "description": "The metabolism of Nicardipine can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00091",
                        "description": "The metabolism of Epinastine can be decreased when combined with Cyclosporine"
                    },
                    {
                        "drugbank-id": "DB00169",
                        "description": "The metabolism of Epinastine can be decreased when combined with Cholecalciferol"
                    },
                    {
                        "drugbank-id": "DB00264",
                        "description": "The metabolism of Epinastine can be decreased when combined with Metoprolol"
                    },
                    {
                        "drugbank-id": "DB00349",
                        "description": "The metabolism of Epinastine can be decreased when combined with Clobazam"
                    },
                    {
                        "drugbank-id": "DB00468",
                        "description": "The metabolism of Epinastine can be decreased when combined with Quinine"
                    },
                    {
                        "drugbank-id": "DB00482",
                        "description": "The metabolism of Epinastine can be decreased when combined with Celecoxib"
                    },
                    {
                        "drugbank-id": "DB00608",
                        "description": "The metabolism of Epinastine can be decreased when combined with Chloroquine"
                    },
                    {
                        "drugbank-id": "DB00752",
                        "description": "The metabolism of Epinastine can be decreased when combined with Tranylcypromine"
                    },
                    {
                        "drugbank-id": "DB00857",
                        "description": "The metabolism of Epinastine can be decreased when combined with Terbinafine"
                    },
                    {
                        "drugbank-id": "DB00932",
                        "description": "The metabolism of Epinastine can be decreased when combined with Tipranavir"
                    },
                    {
                        "drugbank-id": "DB01074",
                        "description": "The metabolism of Epinastine can be decreased when combined with Perhexiline"
                    },
                    {
                        "drugbank-id": "DB01079",
                        "description": "The metabolism of Epinastine can be decreased when combined with Tegaserod"
                    },
                    {
                        "drugbank-id": "DB02703",
                        "description": "The metabolism of Epinastine can be decreased when combined with Fusidic acid"
                    },
                    {
                        "drugbank-id": "DB04871",
                        "description": "The metabolism of Epinastine can be decreased when combined with Lorcaserin"
                    },
                    {
                        "drugbank-id": "DB05812",
                        "description": "The metabolism of Epinastine can be decreased when combined with Abiraterone"
                    },
                    {
                        "drugbank-id": "DB06603",
                        "description": "The metabolism of Epinastine can be decreased when combined with Panobinostat"
                    },
                    {
                        "drugbank-id": "DB06684",
                        "description": "The metabolism of Epinastine can be decreased when combined with Vilazodone"
                    },
                    {
                        "drugbank-id": "DB06708",
                        "description": "The metabolism of Epinastine can be decreased when combined with Lumefantrine"
                    },
                    {
                        "drugbank-id": "DB06729",
                        "description": "The metabolism of Epinastine can be decreased when combined with Sulfaphenazole"
                    },
                    {
                        "drugbank-id": "DB06819",
                        "description": "The metabolism of Epinastine can be decreased when combined with Phenylbutyric acid"
                    },
                    {
                        "drugbank-id": "DB08893",
                        "description": "The metabolism of Epinastine can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB09291",
                        "description": "The metabolism of Epinastine can be decreased when combined with Rolapitant"
                    },
                    {
                        "drugbank-id": "DB11586",
                        "description": "The metabolism of Epinastine can be decreased when combined with Asunaprevir"
                    },
                    {
                        "drugbank-id": "DB12332",
                        "description": "The metabolism of Epinastine can be decreased when combined with Rucaparib"
                    },
                    {
                        "drugbank-id": "DB13174",
                        "description": "The metabolism of Epinastine can be decreased when combined with Rhein"
                    },
                    {
                        "drugbank-id": "DB15982",
                        "description": "The metabolism of Epinastine can be decreased when combined with Berotralstat"
                    },
                    {
                        "drugbank-id": "DB00715",
                        "description": "The metabolism of Paroxetine can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00908",
                        "description": "The metabolism of Quinidine can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00604",
                        "description": "The metabolism of Epinastine can be decreased when combined with Cisapride"
                    },
                    {
                        "drugbank-id": "DB00679",
                        "description": "The metabolism of Epinastine can be decreased when combined with Thioridazine"
                    },
                    {
                        "drugbank-id": "DB01012",
                        "description": "The metabolism of Epinastine can be decreased when combined with Cinacalcet"
                    },
                    {
                        "drugbank-id": "DB01156",
                        "description": "The metabolism of Epinastine can be decreased when combined with Bupropion"
                    },
                    {
                        "drugbank-id": "DB01182",
                        "description": "The metabolism of Epinastine can be decreased when combined with Propafenone"
                    },
                    {
                        "drugbank-id": "DB01218",
                        "description": "The metabolism of Epinastine can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB06595",
                        "description": "The metabolism of Epinastine can be decreased when combined with Midostaurin"
                    },
                    {
                        "drugbank-id": "DB08909",
                        "description": "The metabolism of Epinastine can be decreased when combined with Glycerol phenylbutyrate"
                    },
                    {
                        "drugbank-id": "DB00234",
                        "description": "The risk or severity of adverse effects can be increased when Reboxetine is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00494",
                        "description": "The risk or severity of adverse effects can be increased when Entacapone is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00623",
                        "description": "The risk or severity of adverse effects can be increased when Fluphenazine is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00960",
                        "description": "The risk or severity of adverse effects can be increased when Pindolol is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB01037",
                        "description": "The risk or severity of adverse effects can be increased when Selegiline is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB01323",
                        "description": "The risk or severity of adverse effects can be increased when St John s Wort is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB06512",
                        "description": "The risk or severity of adverse effects can be increased when Deramciclane is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00042",
                        "description": "The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00083",
                        "description": "The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00150",
                        "description": "The risk or severity of adverse effects can be increased when Tryptophan is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00181",
                        "description": "The risk or severity of adverse effects can be increased when Baclofen is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00186",
                        "description": "The risk or severity of adverse effects can be increased when Lorazepam is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00189",
                        "description": "The risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00202",
                        "description": "The risk or severity of adverse effects can be increased when Succinylcholine is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00206",
                        "description": "The risk or severity of adverse effects can be increased when Reserpine is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00216",
                        "description": "The risk or severity of adverse effects can be increased when Eletriptan is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00228",
                        "description": "The risk or severity of adverse effects can be increased when Enflurane is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00231",
                        "description": "The risk or severity of adverse effects can be increased when Temazepam is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00237",
                        "description": "The risk or severity of adverse effects can be increased when Butabarbital is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00241",
                        "description": "The risk or severity of adverse effects can be increased when Butalbital is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00247",
                        "description": "The risk or severity of adverse effects can be increased when Methysergide is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00248",
                        "description": "The risk or severity of adverse effects can be increased when Cabergoline is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00273",
                        "description": "The risk or severity of adverse effects can be increased when Topiramate is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00283",
                        "description": "The risk or severity of adverse effects can be increased when Clemastine is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00292",
                        "description": "The risk or severity of adverse effects can be increased when Etomidate is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00295",
                        "description": "The risk or severity of adverse effects can be increased when Morphine is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00306",
                        "description": "The risk or severity of adverse effects can be increased when Talbutal is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00312",
                        "description": "The risk or severity of adverse effects can be increased when Pentobarbital is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00313",
                        "description": "The risk or severity of adverse effects can be increased when Valproic acid is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00315",
                        "description": "The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00318",
                        "description": "The risk or severity of adverse effects can be increased when Codeine is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00320",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00323",
                        "description": "The risk or severity of adverse effects can be increased when Tolcapone is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00327",
                        "description": "The risk or severity of adverse effects can be increased when Hydromorphone is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00341",
                        "description": "The risk or severity of adverse effects can be increased when Cetirizine is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00344",
                        "description": "The risk or severity of adverse effects can be increased when Protriptyline is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00347",
                        "description": "The risk or severity of adverse effects can be increased when Trimethadione is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00356",
                        "description": "The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00371",
                        "description": "The risk or severity of adverse effects can be increased when Meprobamate is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00372",
                        "description": "The risk or severity of adverse effects can be increased when Thiethylperazine is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00377",
                        "description": "The risk or severity of adverse effects can be increased when Palonosetron is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00391",
                        "description": "The risk or severity of adverse effects can be increased when Sulpiride is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00404",
                        "description": "The risk or severity of adverse effects can be increased when Alprazolam is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00405",
                        "description": "The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00408",
                        "description": "The risk or severity of adverse effects can be increased when Loxapine is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00409",
                        "description": "The risk or severity of adverse effects can be increased when Remoxipride is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00416",
                        "description": "The risk or severity of adverse effects can be increased when Metocurine iodide is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00418",
                        "description": "The risk or severity of adverse effects can be increased when Secobarbital is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00423",
                        "description": "The risk or severity of adverse effects can be increased when Methocarbamol is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00427",
                        "description": "The risk or severity of adverse effects can be increased when Triprolidine is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00433",
                        "description": "The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00454",
                        "description": "The risk or severity of adverse effects can be increased when Meperidine is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00463",
                        "description": "The risk or severity of adverse effects can be increased when Metharbital is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00474",
                        "description": "The risk or severity of adverse effects can be increased when Methohexital is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00475",
                        "description": "The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00497",
                        "description": "The risk or severity of adverse effects can be increased when Oxycodone is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00514",
                        "description": "The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00532",
                        "description": "The risk or severity of adverse effects can be increased when Mephenytoin is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00546",
                        "description": "The risk or severity of adverse effects can be increased when Adinazolam is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00564",
                        "description": "The risk or severity of adverse effects can be increased when Carbamazepine is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00565",
                        "description": "The risk or severity of adverse effects can be increased when Cisatracurium is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00574",
                        "description": "The risk or severity of adverse effects can be increased when Fenfluramine is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00579",
                        "description": "The risk or severity of adverse effects can be increased when Mazindol is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00588",
                        "description": "The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00589",
                        "description": "The risk or severity of adverse effects can be increased when Lisuride is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00593",
                        "description": "The risk or severity of adverse effects can be increased when Ethosuximide is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00599",
                        "description": "The risk or severity of adverse effects can be increased when Thiopental is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00601",
                        "description": "The risk or severity of adverse effects can be increased when Linezolid is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00611",
                        "description": "The risk or severity of adverse effects can be increased when Butorphanol is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00614",
                        "description": "The risk or severity of adverse effects can be increased when Furazolidone is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00617",
                        "description": "The risk or severity of adverse effects can be increased when Paramethadione is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00625",
                        "description": "The risk or severity of adverse effects can be increased when Efavirenz is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00628",
                        "description": "The risk or severity of adverse effects can be increased when Clorazepic acid is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00633",
                        "description": "The risk or severity of adverse effects can be increased when Dexmedetomidine is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00645",
                        "description": "The risk or severity of adverse effects can be increased when Dyclonine is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00647",
                        "description": "The risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00652",
                        "description": "The risk or severity of adverse effects can be increased when Pentazocine is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00660",
                        "description": "The risk or severity of adverse effects can be increased when Metaxalone is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00662",
                        "description": "The risk or severity of adverse effects can be increased when Trimethobenzamide is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00669",
                        "description": "The risk or severity of adverse effects can be increased when Sumatriptan is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00680",
                        "description": "The risk or severity of adverse effects can be increased when Moricizine is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00683",
                        "description": "The risk or severity of adverse effects can be increased when Midazolam is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00690",
                        "description": "The risk or severity of adverse effects can be increased when Flurazepam is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00696",
                        "description": "The risk or severity of adverse effects can be increased when Ergotamine is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00697",
                        "description": "The risk or severity of adverse effects can be increased when Tizanidine is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00708",
                        "description": "The risk or severity of adverse effects can be increased when Sufentanil is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00714",
                        "description": "The risk or severity of adverse effects can be increased when Apomorphine is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00721",
                        "description": "The risk or severity of adverse effects can be increased when Procaine is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00732",
                        "description": "The risk or severity of adverse effects can be increased when Atracurium besylate is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00734",
                        "description": "The risk or severity of adverse effects can be increased when Risperidone is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00737",
                        "description": "The risk or severity of adverse effects can be increased when Meclizine is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00740",
                        "description": "The risk or severity of adverse effects can be increased when Riluzole is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00748",
                        "description": "The risk or severity of adverse effects can be increased when Carbinoxamine is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00753",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Isoflurane"
                    },
                    {
                        "drugbank-id": "DB00754",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Ethotoin"
                    },
                    {
                        "drugbank-id": "DB00757",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Dolasetron"
                    },
                    {
                        "drugbank-id": "DB00776",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Oxcarbazepine"
                    },
                    {
                        "drugbank-id": "DB00780",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Phenelzine"
                    },
                    {
                        "drugbank-id": "DB00794",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Primidone"
                    },
                    {
                        "drugbank-id": "DB00801",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Halazepam"
                    },
                    {
                        "drugbank-id": "DB00802",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Alfentanil"
                    },
                    {
                        "drugbank-id": "DB00805",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Minaprine"
                    },
                    {
                        "drugbank-id": "DB00813",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Fentanyl"
                    },
                    {
                        "drugbank-id": "DB00818",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Propofol"
                    },
                    {
                        "drugbank-id": "DB00819",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Acetazolamide"
                    },
                    {
                        "drugbank-id": "DB00829",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Diazepam"
                    },
                    {
                        "drugbank-id": "DB00831",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Trifluoperazine"
                    },
                    {
                        "drugbank-id": "DB00832",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Phensuximide"
                    },
                    {
                        "drugbank-id": "DB00837",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Progabide"
                    },
                    {
                        "drugbank-id": "DB00842",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Oxazepam"
                    },
                    {
                        "drugbank-id": "DB00843",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Donepezil"
                    },
                    {
                        "drugbank-id": "DB00844",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00849",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Methylphenobarbital"
                    },
                    {
                        "drugbank-id": "DB00850",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Perphenazine"
                    },
                    {
                        "drugbank-id": "DB00854",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Levorphanol"
                    },
                    {
                        "drugbank-id": "DB00866",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Alprenolol"
                    },
                    {
                        "drugbank-id": "DB00889",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Granisetron"
                    },
                    {
                        "drugbank-id": "DB00897",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Triazolam"
                    },
                    {
                        "drugbank-id": "DB00899",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Remifentanil"
                    },
                    {
                        "drugbank-id": "DB00904",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00906",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Tiagabine"
                    },
                    {
                        "drugbank-id": "DB00909",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Zonisamide"
                    },
                    {
                        "drugbank-id": "DB00918",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Almotriptan"
                    },
                    {
                        "drugbank-id": "DB00933",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00941",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Hexafluronium"
                    },
                    {
                        "drugbank-id": "DB00949",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Felbamate"
                    },
                    {
                        "drugbank-id": "DB00952",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Naratriptan"
                    },
                    {
                        "drugbank-id": "DB00953",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Rizatriptan"
                    },
                    {
                        "drugbank-id": "DB00962",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Zaleplon"
                    },
                    {
                        "drugbank-id": "DB00967",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Desloratadine"
                    },
                    {
                        "drugbank-id": "DB00969",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Alosetron"
                    },
                    {
                        "drugbank-id": "DB00980",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Ramelteon"
                    },
                    {
                        "drugbank-id": "DB00985",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Dimenhydrinate"
                    },
                    {
                        "drugbank-id": "DB00996",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Gabapentin"
                    },
                    {
                        "drugbank-id": "DB00998",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Frovatriptan"
                    },
                    {
                        "drugbank-id": "DB01018",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Guanfacine"
                    },
                    {
                        "drugbank-id": "DB01028",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Methoxyflurane"
                    },
                    {
                        "drugbank-id": "DB01049",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB01063",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Acetophenazine"
                    },
                    {
                        "drugbank-id": "DB01065",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Melatonin"
                    },
                    {
                        "drugbank-id": "DB01068",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Clonazepam"
                    },
                    {
                        "drugbank-id": "DB01080",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Vigabatrin"
                    },
                    {
                        "drugbank-id": "DB01081",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Diphenoxylate"
                    },
                    {
                        "drugbank-id": "DB01107",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Methyprylon"
                    },
                    {
                        "drugbank-id": "DB01114",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Chlorpheniramine"
                    },
                    {
                        "drugbank-id": "DB01121",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Phenacemide"
                    },
                    {
                        "drugbank-id": "DB01154",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Thiamylal"
                    },
                    {
                        "drugbank-id": "DB01159",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Halothane"
                    },
                    {
                        "drugbank-id": "DB01168",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Procarbazine"
                    },
                    {
                        "drugbank-id": "DB01171",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Moclobemide"
                    },
                    {
                        "drugbank-id": "DB01176",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Cyclizine"
                    },
                    {
                        "drugbank-id": "DB01178",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Chlormezanone"
                    },
                    {
                        "drugbank-id": "DB01186",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Pergolide"
                    },
                    {
                        "drugbank-id": "DB01189",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Desflurane"
                    },
                    {
                        "drugbank-id": "DB01192",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Oxymorphone"
                    },
                    {
                        "drugbank-id": "DB01199",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Tubocurarine"
                    },
                    {
                        "drugbank-id": "DB01200",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Bromocriptine"
                    },
                    {
                        "drugbank-id": "DB01202",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Levetiracetam"
                    },
                    {
                        "drugbank-id": "DB01209",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Dezocine"
                    },
                    {
                        "drugbank-id": "DB01215",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Estazolam"
                    },
                    {
                        "drugbank-id": "DB01219",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Dantrolene"
                    },
                    {
                        "drugbank-id": "DB01221",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Ketamine"
                    },
                    {
                        "drugbank-id": "DB01227",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Levacetylmethadol"
                    },
                    {
                        "drugbank-id": "DB01235",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Levodopa"
                    },
                    {
                        "drugbank-id": "DB01236",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Sevoflurane"
                    },
                    {
                        "drugbank-id": "DB01245",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Decamethonium"
                    },
                    {
                        "drugbank-id": "DB01246",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Alimemazine"
                    },
                    {
                        "drugbank-id": "DB01247",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Isocarboxazid"
                    },
                    {
                        "drugbank-id": "DB01253",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Ergometrine"
                    },
                    {
                        "drugbank-id": "DB01267",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Paliperidone"
                    },
                    {
                        "drugbank-id": "DB01339",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Vecuronium"
                    },
                    {
                        "drugbank-id": "DB01351",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Amobarbital"
                    },
                    {
                        "drugbank-id": "DB01352",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Aprobarbital"
                    },
                    {
                        "drugbank-id": "DB01353",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Butobarbital"
                    },
                    {
                        "drugbank-id": "DB01354",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Heptabarbital"
                    },
                    {
                        "drugbank-id": "DB01355",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Hexobarbital"
                    },
                    {
                        "drugbank-id": "DB01356",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01359",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Penbutolol"
                    },
                    {
                        "drugbank-id": "DB01367",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Rasagiline"
                    },
                    {
                        "drugbank-id": "DB01392",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Yohimbine"
                    },
                    {
                        "drugbank-id": "DB01433",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Methadyl acetate"
                    },
                    {
                        "drugbank-id": "DB01437",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Glutethimide"
                    },
                    {
                        "drugbank-id": "DB01440",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with gamma Hydroxybutyric acid"
                    },
                    {
                        "drugbank-id": "DB01445",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Bufotenine"
                    },
                    {
                        "drugbank-id": "DB01450",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Dihydroetorphine"
                    },
                    {
                        "drugbank-id": "DB01452",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Diamorphine"
                    },
                    {
                        "drugbank-id": "DB01463",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Fencamfamin"
                    },
                    {
                        "drugbank-id": "DB01466",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Ethylmorphine"
                    },
                    {
                        "drugbank-id": "DB01472",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with 4 Methoxyamphetamine"
                    },
                    {
                        "drugbank-id": "DB01483",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Barbital"
                    },
                    {
                        "drugbank-id": "DB01488",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Dimethyltryptamine"
                    },
                    {
                        "drugbank-id": "DB01489",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Camazepam"
                    },
                    {
                        "drugbank-id": "DB01495",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Dichloralphenazone"
                    },
                    {
                        "drugbank-id": "DB01497",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Etorphine"
                    },
                    {
                        "drugbank-id": "DB01501",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Difenoxin"
                    },
                    {
                        "drugbank-id": "DB01511",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Delorazepam"
                    },
                    {
                        "drugbank-id": "DB01529",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Dextromoramide"
                    },
                    {
                        "drugbank-id": "DB01531",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Desomorphine"
                    },
                    {
                        "drugbank-id": "DB01534",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Chlorhexadol"
                    },
                    {
                        "drugbank-id": "DB01535",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Carfentanil"
                    },
                    {
                        "drugbank-id": "DB01544",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Flunitrazepam"
                    },
                    {
                        "drugbank-id": "DB01545",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Ethyl loflazepate"
                    },
                    {
                        "drugbank-id": "DB01547",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Drotebanol"
                    },
                    {
                        "drugbank-id": "DB01551",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Dihydrocodeine"
                    },
                    {
                        "drugbank-id": "DB01553",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Cloxazolam"
                    },
                    {
                        "drugbank-id": "DB01555",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Alphacetylmethadol"
                    },
                    {
                        "drugbank-id": "DB01558",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Bromazepam"
                    },
                    {
                        "drugbank-id": "DB01559",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Clotiazepam"
                    },
                    {
                        "drugbank-id": "DB01560",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Cathinone"
                    },
                    {
                        "drugbank-id": "DB01563",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Chloral hydrate"
                    },
                    {
                        "drugbank-id": "DB01565",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Dihydromorphine"
                    },
                    {
                        "drugbank-id": "DB01567",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Fludiazepam"
                    },
                    {
                        "drugbank-id": "DB01580",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Oxprenolol"
                    },
                    {
                        "drugbank-id": "DB01587",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Ketazolam"
                    },
                    {
                        "drugbank-id": "DB01588",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Prazepam"
                    },
                    {
                        "drugbank-id": "DB01589",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Quazepam"
                    },
                    {
                        "drugbank-id": "DB01594",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Cinolazepam"
                    },
                    {
                        "drugbank-id": "DB01595",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Nitrazepam"
                    },
                    {
                        "drugbank-id": "DB01608",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Periciazine"
                    },
                    {
                        "drugbank-id": "DB01614",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Acepromazine"
                    },
                    {
                        "drugbank-id": "DB01615",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Aceprometazine"
                    },
                    {
                        "drugbank-id": "DB01616",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Alverine"
                    },
                    {
                        "drugbank-id": "DB01618",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Molindone"
                    },
                    {
                        "drugbank-id": "DB01621",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Pipotiazine"
                    },
                    {
                        "drugbank-id": "DB01622",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Thioproperazine"
                    },
                    {
                        "drugbank-id": "DB01623",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Thiothixene"
                    },
                    {
                        "drugbank-id": "DB01624",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Zuclopenthixol"
                    },
                    {
                        "drugbank-id": "DB01626",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Pargyline"
                    },
                    {
                        "drugbank-id": "DB01954",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Rolipram"
                    },
                    {
                        "drugbank-id": "DB02207",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with 7 Nitroindazole"
                    },
                    {
                        "drugbank-id": "DB02234",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with S Ethylisothiourea"
                    },
                    {
                        "drugbank-id": "DB02852",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Domoic Acid"
                    },
                    {
                        "drugbank-id": "DB02959",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Oxitriptan"
                    },
                    {
                        "drugbank-id": "DB03575",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Phencyclidine"
                    },
                    {
                        "drugbank-id": "DB04017",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Clorgiline"
                    },
                    {
                        "drugbank-id": "DB04165",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Valpromide"
                    },
                    {
                        "drugbank-id": "DB04325",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Phenethylamine"
                    },
                    {
                        "drugbank-id": "DB04599",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Aniracetam"
                    },
                    {
                        "drugbank-id": "DB04818",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Iproniazid"
                    },
                    {
                        "drugbank-id": "DB04819",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Methapyrilene"
                    },
                    {
                        "drugbank-id": "DB04820",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Nialamide"
                    },
                    {
                        "drugbank-id": "DB04821",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Nomifensine"
                    },
                    {
                        "drugbank-id": "DB04827",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Urethane"
                    },
                    {
                        "drugbank-id": "DB04829",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Lysergic acid diethylamide"
                    },
                    {
                        "drugbank-id": "DB04833",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Methaqualone"
                    },
                    {
                        "drugbank-id": "DB04836",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Amineptine"
                    },
                    {
                        "drugbank-id": "DB04841",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Flunarizine"
                    },
                    {
                        "drugbank-id": "DB04842",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Fluspirilene"
                    },
                    {
                        "drugbank-id": "DB04872",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Osanetant"
                    },
                    {
                        "drugbank-id": "DB04885",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Cilansetron"
                    },
                    {
                        "drugbank-id": "DB04888",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Bifeprunox"
                    },
                    {
                        "drugbank-id": "DB04903",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Pagoclone"
                    },
                    {
                        "drugbank-id": "DB04908",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Flibanserin"
                    },
                    {
                        "drugbank-id": "DB04917",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Renzapride"
                    },
                    {
                        "drugbank-id": "DB04946",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Iloperidone"
                    },
                    {
                        "drugbank-id": "DB04953",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Ezogabine"
                    },
                    {
                        "drugbank-id": "DB05227",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with APD791"
                    },
                    {
                        "drugbank-id": "DB05232",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Tetrodotoxin"
                    },
                    {
                        "drugbank-id": "DB05246",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Methsuximide"
                    },
                    {
                        "drugbank-id": "DB05316",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Pimavanserin"
                    },
                    {
                        "drugbank-id": "DB05541",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Brivaracetam"
                    },
                    {
                        "drugbank-id": "DB05542",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Naronapride"
                    },
                    {
                        "drugbank-id": "DB05562",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Naluzotan"
                    },
                    {
                        "drugbank-id": "DB05607",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with PRX 08066"
                    },
                    {
                        "drugbank-id": "DB05687",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with BL 1020"
                    },
                    {
                        "drugbank-id": "DB05710",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Gantacurium"
                    },
                    {
                        "drugbank-id": "DB06016",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Cariprazine"
                    },
                    {
                        "drugbank-id": "DB06077",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Lumateperone"
                    },
                    {
                        "drugbank-id": "DB06109",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with YKP 1358"
                    },
                    {
                        "drugbank-id": "DB06144",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Sertindole"
                    },
                    {
                        "drugbank-id": "DB06148",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Mianserin"
                    },
                    {
                        "drugbank-id": "DB06216",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Asenapine"
                    },
                    {
                        "drugbank-id": "DB06218",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Lacosamide"
                    },
                    {
                        "drugbank-id": "DB06264",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Tolperisone"
                    },
                    {
                        "drugbank-id": "DB06282",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Levocetirizine"
                    },
                    {
                        "drugbank-id": "DB06283",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Ziconotide"
                    },
                    {
                        "drugbank-id": "DB06288",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Amisulpride"
                    },
                    {
                        "drugbank-id": "DB06446",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Dotarizine"
                    },
                    {
                        "drugbank-id": "DB06458",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Remacemide"
                    },
                    {
                        "drugbank-id": "DB06470",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Clomethiazole"
                    },
                    {
                        "drugbank-id": "DB06527",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Tramiprosate"
                    },
                    {
                        "drugbank-id": "DB06529",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Ocinaplon"
                    },
                    {
                        "drugbank-id": "DB06554",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Gaboxadol"
                    },
                    {
                        "drugbank-id": "DB06579",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Adipiplon"
                    },
                    {
                        "drugbank-id": "DB06582",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Dextofisopam"
                    },
                    {
                        "drugbank-id": "DB06594",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Agomelatine"
                    },
                    {
                        "drugbank-id": "DB06654",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Safinamide"
                    },
                    {
                        "drugbank-id": "DB06660",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Saredutant"
                    },
                    {
                        "drugbank-id": "DB06678",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Esmirtazapine"
                    },
                    {
                        "drugbank-id": "DB06690",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Nitrous oxide"
                    },
                    {
                        "drugbank-id": "DB06691",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB06716",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Fospropofol"
                    },
                    {
                        "drugbank-id": "DB06738",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Ketobemidone"
                    },
                    {
                        "drugbank-id": "DB06753",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Triclofos"
                    },
                    {
                        "drugbank-id": "DB06770",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Benzyl alcohol"
                    },
                    {
                        "drugbank-id": "DB06797",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Mebutamate"
                    },
                    {
                        "drugbank-id": "DB08059",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Wortmannin"
                    },
                    {
                        "drugbank-id": "DB08329",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Sulthiame"
                    },
                    {
                        "drugbank-id": "DB08550",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with 7 8 Dichloro 1 2 3 4 tetrahydroisoquinoline"
                    },
                    {
                        "drugbank-id": "DB08810",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Cinitapride"
                    },
                    {
                        "drugbank-id": "DB08811",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Tofisopam"
                    },
                    {
                        "drugbank-id": "DB08815",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Lurasidone"
                    },
                    {
                        "drugbank-id": "DB08839",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Serotonin"
                    },
                    {
                        "drugbank-id": "DB08861",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with DPDPE"
                    },
                    {
                        "drugbank-id": "DB08872",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Gabapentin enacarbil"
                    },
                    {
                        "drugbank-id": "DB08892",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Arbaclofen Placarbil"
                    },
                    {
                        "drugbank-id": "DB08910",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB08922",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Perospirone"
                    },
                    {
                        "drugbank-id": "DB08927",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Amperozide"
                    },
                    {
                        "drugbank-id": "DB08954",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Ifenprodil"
                    },
                    {
                        "drugbank-id": "DB08960",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Hexamethonium"
                    },
                    {
                        "drugbank-id": "DB08986",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Etifoxine"
                    },
                    {
                        "drugbank-id": "DB08992",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Eperisone"
                    },
                    {
                        "drugbank-id": "DB08996",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Dimetacrine"
                    },
                    {
                        "drugbank-id": "DB09000",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Cyamemazine"
                    },
                    {
                        "drugbank-id": "DB09001",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Barbexaclone"
                    },
                    {
                        "drugbank-id": "DB09011",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Beclamide"
                    },
                    {
                        "drugbank-id": "DB09014",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Captodiame"
                    },
                    {
                        "drugbank-id": "DB09016",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Butriptyline"
                    },
                    {
                        "drugbank-id": "DB09017",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Brotizolam"
                    },
                    {
                        "drugbank-id": "DB09021",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Benzoctamine"
                    },
                    {
                        "drugbank-id": "DB09068",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Vortioxetine"
                    },
                    {
                        "drugbank-id": "DB09071",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Tasimelteon"
                    },
                    {
                        "drugbank-id": "DB09118",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Stiripentol"
                    },
                    {
                        "drugbank-id": "DB09119",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Eslicarbazepine acetate"
                    },
                    {
                        "drugbank-id": "DB09128",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Brexpiprazole"
                    },
                    {
                        "drugbank-id": "DB09166",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Etizolam"
                    },
                    {
                        "drugbank-id": "DB09174",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Lofentanil"
                    },
                    {
                        "drugbank-id": "DB09184",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Edivoxetine"
                    },
                    {
                        "drugbank-id": "DB09185",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Viloxazine"
                    },
                    {
                        "drugbank-id": "DB09186",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Nisoxetine"
                    },
                    {
                        "drugbank-id": "DB09187",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Lortalamine"
                    },
                    {
                        "drugbank-id": "DB09190",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Talopram"
                    },
                    {
                        "drugbank-id": "DB09194",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Etoperidone"
                    },
                    {
                        "drugbank-id": "DB09223",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Blonanserin"
                    },
                    {
                        "drugbank-id": "DB09224",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Melperone"
                    },
                    {
                        "drugbank-id": "DB09225",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Zotepine"
                    },
                    {
                        "drugbank-id": "DB09226",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Brilaroxazine"
                    },
                    {
                        "drugbank-id": "DB09241",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Methylene blue"
                    },
                    {
                        "drugbank-id": "DB09243",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Hydracarbazine"
                    },
                    {
                        "drugbank-id": "DB09244",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Pirlindole"
                    },
                    {
                        "drugbank-id": "DB09245",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Toloxatone"
                    },
                    {
                        "drugbank-id": "DB09246",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Benmoxin"
                    },
                    {
                        "drugbank-id": "DB09247",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Iproclozide"
                    },
                    {
                        "drugbank-id": "DB09248",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Mebanazine"
                    },
                    {
                        "drugbank-id": "DB09249",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Octamoxin"
                    },
                    {
                        "drugbank-id": "DB09250",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Pheniprazine"
                    },
                    {
                        "drugbank-id": "DB09251",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Phenoxypropazine"
                    },
                    {
                        "drugbank-id": "DB09252",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Pivhydrazine"
                    },
                    {
                        "drugbank-id": "DB09253",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Safrazine"
                    },
                    {
                        "drugbank-id": "DB09254",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Caroxazone"
                    },
                    {
                        "drugbank-id": "DB09286",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Pipamperone"
                    },
                    {
                        "drugbank-id": "DB09289",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Tianeptine"
                    },
                    {
                        "drugbank-id": "DB09290",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Ramosetron"
                    },
                    {
                        "drugbank-id": "DB09307",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Oxaprotiline"
                    },
                    {
                        "drugbank-id": "DB11130",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Opium"
                    },
                    {
                        "drugbank-id": "DB11156",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Pyrantel"
                    },
                    {
                        "drugbank-id": "DB11371",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Alfaxalone"
                    },
                    {
                        "drugbank-id": "DB11376",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Azaperone"
                    },
                    {
                        "drugbank-id": "DB11400",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Doramectin"
                    },
                    {
                        "drugbank-id": "DB11428",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Medetomidine"
                    },
                    {
                        "drugbank-id": "DB11477",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Xylazine"
                    },
                    {
                        "drugbank-id": "DB11540",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Propiopromazine"
                    },
                    {
                        "drugbank-id": "DB11543",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Romifidine"
                    },
                    {
                        "drugbank-id": "DB11549",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Tiletamine"
                    },
                    {
                        "drugbank-id": "DB11552",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Tricaine"
                    },
                    {
                        "drugbank-id": "DB11555",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Zolazepam"
                    },
                    {
                        "drugbank-id": "DB11556",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Detomidine"
                    },
                    {
                        "drugbank-id": "DB11582",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Thiocolchicoside"
                    },
                    {
                        "drugbank-id": "DB11609",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Normethadone"
                    },
                    {
                        "drugbank-id": "DB11664",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Psilocybin"
                    },
                    {
                        "drugbank-id": "DB11675",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Mosapride"
                    },
                    {
                        "drugbank-id": "DB11686",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Iferanserin"
                    },
                    {
                        "drugbank-id": "DB11699",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Tropisetron"
                    },
                    {
                        "drugbank-id": "DB11755",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB11859",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Brexanolone"
                    },
                    {
                        "drugbank-id": "DB11868",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Etiracetam"
                    },
                    {
                        "drugbank-id": "DB11889",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Lanicemine"
                    },
                    {
                        "drugbank-id": "DB11957",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Idalopirdine"
                    },
                    {
                        "drugbank-id": "DB12071",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Vabicaserin"
                    },
                    {
                        "drugbank-id": "DB12093",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Tetrahydropalmatine"
                    },
                    {
                        "drugbank-id": "DB12105",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Imagabalin"
                    },
                    {
                        "drugbank-id": "DB12110",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with m Chlorophenylpiperazine"
                    },
                    {
                        "drugbank-id": "DB12111",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with MK 212"
                    },
                    {
                        "drugbank-id": "DB12131",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Vinpocetine"
                    },
                    {
                        "drugbank-id": "DB12163",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Sarpogrelate"
                    },
                    {
                        "drugbank-id": "DB12177",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Eplivanserin"
                    },
                    {
                        "drugbank-id": "DB12184",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Gepirone"
                    },
                    {
                        "drugbank-id": "DB12229",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Cerlapirdine"
                    },
                    {
                        "drugbank-id": "DB12273",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Ecopipam"
                    },
                    {
                        "drugbank-id": "DB12308",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Eltanolone"
                    },
                    {
                        "drugbank-id": "DB12327",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Salvinorin A"
                    },
                    {
                        "drugbank-id": "DB12338",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Carisbamate"
                    },
                    {
                        "drugbank-id": "DB12361",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Piclozotan"
                    },
                    {
                        "drugbank-id": "DB12395",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Esreboxetine"
                    },
                    {
                        "drugbank-id": "DB12401",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Bromperidol"
                    },
                    {
                        "drugbank-id": "DB12404",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Remimazolam"
                    },
                    {
                        "drugbank-id": "DB12427",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Orvepitant"
                    },
                    {
                        "drugbank-id": "DB12465",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Ketanserin"
                    },
                    {
                        "drugbank-id": "DB12492",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Piritramide"
                    },
                    {
                        "drugbank-id": "DB12518",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Raclopride"
                    },
                    {
                        "drugbank-id": "DB12537",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Benzodiazepine"
                    },
                    {
                        "drugbank-id": "DB12576",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with AZD 3043"
                    },
                    {
                        "drugbank-id": "DB12590",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Indiplon"
                    },
                    {
                        "drugbank-id": "DB12661",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Urapidil"
                    },
                    {
                        "drugbank-id": "DB12710",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Perazine"
                    },
                    {
                        "drugbank-id": "DB12725",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with TD 8954"
                    },
                    {
                        "drugbank-id": "DB12833",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Tandospirone"
                    },
                    {
                        "drugbank-id": "DB12867",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Benperidol"
                    },
                    {
                        "drugbank-id": "DB12883",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Eltoprazine"
                    },
                    {
                        "drugbank-id": "DB12930",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Opipramol"
                    },
                    {
                        "drugbank-id": "DB12951",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Pivagabine"
                    },
                    {
                        "drugbank-id": "DB12958",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Prothipendyl"
                    },
                    {
                        "drugbank-id": "DB12989",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Neosaxitoxin"
                    },
                    {
                        "drugbank-id": "DB13014",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Hypericin"
                    },
                    {
                        "drugbank-id": "DB13025",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Tiapride"
                    },
                    {
                        "drugbank-id": "DB13082",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Nefiracetam"
                    },
                    {
                        "drugbank-id": "DB13099",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Valnoctamide"
                    },
                    {
                        "drugbank-id": "DB13114",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Amitriptylinoxide"
                    },
                    {
                        "drugbank-id": "DB13160",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Alphaprodine"
                    },
                    {
                        "drugbank-id": "DB13213",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Butaperazine"
                    },
                    {
                        "drugbank-id": "DB13219",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Medifoxamine"
                    },
                    {
                        "drugbank-id": "DB13221",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Apronalide"
                    },
                    {
                        "drugbank-id": "DB13225",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Dibenzepin"
                    },
                    {
                        "drugbank-id": "DB13234",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Propanidid"
                    },
                    {
                        "drugbank-id": "DB13246",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Quinupramine"
                    },
                    {
                        "drugbank-id": "DB13253",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Proxibarbal"
                    },
                    {
                        "drugbank-id": "DB13256",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Clothiapine"
                    },
                    {
                        "drugbank-id": "DB13273",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Sultopride"
                    },
                    {
                        "drugbank-id": "DB13295",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Atracurium"
                    },
                    {
                        "drugbank-id": "DB13303",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Febarbamate"
                    },
                    {
                        "drugbank-id": "DB13323",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Trichloroethylene"
                    },
                    {
                        "drugbank-id": "DB13324",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Tetrazepam"
                    },
                    {
                        "drugbank-id": "DB13331",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Pyrithyldione"
                    },
                    {
                        "drugbank-id": "DB13335",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Pinazepam"
                    },
                    {
                        "drugbank-id": "DB13352",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Deanol"
                    },
                    {
                        "drugbank-id": "DB13354",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Phenprobamate"
                    },
                    {
                        "drugbank-id": "DB13357",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Styramate"
                    },
                    {
                        "drugbank-id": "DB13362",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Pheneturide"
                    },
                    {
                        "drugbank-id": "DB13370",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Bromisoval"
                    },
                    {
                        "drugbank-id": "DB13377",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Vinbarbital"
                    },
                    {
                        "drugbank-id": "DB13382",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Chlorproethazine"
                    },
                    {
                        "drugbank-id": "DB13384",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Melitracen"
                    },
                    {
                        "drugbank-id": "DB13396",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Neocitrullamon"
                    },
                    {
                        "drugbank-id": "DB13402",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Acetylglycinamide chloral hydrate"
                    },
                    {
                        "drugbank-id": "DB13403",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Oxypertine"
                    },
                    {
                        "drugbank-id": "DB13411",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Lofepramine"
                    },
                    {
                        "drugbank-id": "DB13414",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Fenyramidol"
                    },
                    {
                        "drugbank-id": "DB13420",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Thiazinam"
                    },
                    {
                        "drugbank-id": "DB13437",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Medazepam"
                    },
                    {
                        "drugbank-id": "DB13454",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Nicomorphine"
                    },
                    {
                        "drugbank-id": "DB13455",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Phenibut"
                    },
                    {
                        "drugbank-id": "DB13457",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Oxaflozane"
                    },
                    {
                        "drugbank-id": "DB13478",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Meptazinol"
                    },
                    {
                        "drugbank-id": "DB13496",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Iprindole"
                    },
                    {
                        "drugbank-id": "DB13520",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Metergoline"
                    },
                    {
                        "drugbank-id": "DB13522",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Mebicar"
                    },
                    {
                        "drugbank-id": "DB13523",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Veralipride"
                    },
                    {
                        "drugbank-id": "DB13534",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Gedocarnil"
                    },
                    {
                        "drugbank-id": "DB13541",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Iprazochrome"
                    },
                    {
                        "drugbank-id": "DB13550",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Bifemelane"
                    },
                    {
                        "drugbank-id": "DB13552",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Trifluperidol"
                    },
                    {
                        "drugbank-id": "DB13554",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Moperone"
                    },
                    {
                        "drugbank-id": "DB13557",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Thiopropazate"
                    },
                    {
                        "drugbank-id": "DB13572",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Emylcamate"
                    },
                    {
                        "drugbank-id": "DB13577",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Allobarbital"
                    },
                    {
                        "drugbank-id": "DB13584",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Gallamine"
                    },
                    {
                        "drugbank-id": "DB13588",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Naftidrofuryl"
                    },
                    {
                        "drugbank-id": "DB13598",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Diethyl ether"
                    },
                    {
                        "drugbank-id": "DB13601",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Oxiracetam"
                    },
                    {
                        "drugbank-id": "DB13605",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Phenoperidine"
                    },
                    {
                        "drugbank-id": "DB13606",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Phenazocine"
                    },
                    {
                        "drugbank-id": "DB13623",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Fabomotizole"
                    },
                    {
                        "drugbank-id": "DB13642",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Pridinol"
                    },
                    {
                        "drugbank-id": "DB13643",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Loprazolam"
                    },
                    {
                        "drugbank-id": "DB13648",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Alcuronium"
                    },
                    {
                        "drugbank-id": "DB13662",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Hexapropymate"
                    },
                    {
                        "drugbank-id": "DB13665",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Fluanisone"
                    },
                    {
                        "drugbank-id": "DB13676",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Mosapramine"
                    },
                    {
                        "drugbank-id": "DB13687",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Niaprazine"
                    },
                    {
                        "drugbank-id": "DB13690",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Vinyl ether"
                    },
                    {
                        "drugbank-id": "DB13733",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Methylpentynol"
                    },
                    {
                        "drugbank-id": "DB13737",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Cyclobarbital"
                    },
                    {
                        "drugbank-id": "DB13745",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Fazadinium bromide"
                    },
                    {
                        "drugbank-id": "DB13754",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Mephenoxalone"
                    },
                    {
                        "drugbank-id": "DB13770",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Vinylbital"
                    },
                    {
                        "drugbank-id": "DB13782",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Imipramine oxide"
                    },
                    {
                        "drugbank-id": "DB13784",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Dixyrazine"
                    },
                    {
                        "drugbank-id": "DB13787",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Tilidine"
                    },
                    {
                        "drugbank-id": "DB13791",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Penfluridol"
                    },
                    {
                        "drugbank-id": "DB13799",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Ethadione"
                    },
                    {
                        "drugbank-id": "DB13805",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Reposal"
                    },
                    {
                        "drugbank-id": "DB13817",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Carbromal"
                    },
                    {
                        "drugbank-id": "DB13837",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Doxefazepam"
                    },
                    {
                        "drugbank-id": "DB13841",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Clopenthixol"
                    },
                    {
                        "drugbank-id": "DB13872",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Lormetazepam"
                    },
                    {
                        "drugbank-id": "DB13875",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Harmaline"
                    },
                    {
                        "drugbank-id": "DB13876",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Brofaromine"
                    },
                    {
                        "drugbank-id": "DB13948",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with N 2 hydroxybenzyl 2 5 dimethoxy 4 cyanophenylethylamine"
                    },
                    {
                        "drugbank-id": "DB13984",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Cyclopropane"
                    },
                    {
                        "drugbank-id": "DB13993",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with MRK 409"
                    },
                    {
                        "drugbank-id": "DB14010",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with 5 methoxy N N dimethyltryptamine"
                    },
                    {
                        "drugbank-id": "DB14028",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Nordazepam"
                    },
                    {
                        "drugbank-id": "DB14050",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Cannabidivarin"
                    },
                    {
                        "drugbank-id": "DB14509",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Lithium carbonate"
                    },
                    {
                        "drugbank-id": "DB14575",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Eslicarbazepine"
                    },
                    {
                        "drugbank-id": "DB14651",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Perphenazine enanthate"
                    },
                    {
                        "drugbank-id": "DB14672",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Oxazepam acetate"
                    },
                    {
                        "drugbank-id": "DB14715",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Cinazepam"
                    },
                    {
                        "drugbank-id": "DB14718",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Pyrazolam"
                    },
                    {
                        "drugbank-id": "DB14719",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Bentazepam"
                    },
                    {
                        "drugbank-id": "DB14754",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Solriamfetol"
                    },
                    {
                        "drugbank-id": "DB15203",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with JNJ 26489112"
                    },
                    {
                        "drugbank-id": "DB15360",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Carfentanil C 11"
                    },
                    {
                        "drugbank-id": "DB06783",
                        "description": "Epinastine can cause a decrease in the absorption of Prussian blue resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09146",
                        "description": "Epinastine can cause a decrease in the absorption of Iron sucrose resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09501",
                        "description": "Epinastine can cause a decrease in the absorption of Ferric ammonium citrate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09507",
                        "description": "Epinastine can cause a decrease in the absorption of Ferumoxsil resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09508",
                        "description": "Epinastine can cause a decrease in the absorption of Ferumoxides resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11171",
                        "description": "Epinastine can cause a decrease in the absorption of Ferric sulfate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11210",
                        "description": "Epinastine can cause a decrease in the absorption of Ferrous bisglycinate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11417",
                        "description": "Epinastine can cause a decrease in the absorption of Gleptoferron resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11576",
                        "description": "Epinastine can cause a decrease in the absorption of Ferric oxide resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB12821",
                        "description": "Epinastine can cause a decrease in the absorption of Perflubutane resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13257",
                        "description": "Epinastine can cause a decrease in the absorption of Ferrous sulfate anhydrous resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13381",
                        "description": "Epinastine can cause a decrease in the absorption of Sodium feredetate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13423",
                        "description": "Epinastine can cause a decrease in the absorption of Ferric hydroxide resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13949",
                        "description": "Epinastine can cause a decrease in the absorption of Ferric cation resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14488",
                        "description": "Epinastine can cause a decrease in the absorption of Ferrous gluconate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14489",
                        "description": "Epinastine can cause a decrease in the absorption of Ferrous succinate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14491",
                        "description": "Epinastine can cause a decrease in the absorption of Ferrous fumarate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14520",
                        "description": "Epinastine can cause a decrease in the absorption of Tetraferric tricitrate decahydrate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14695",
                        "description": "Epinastine can cause a decrease in the absorption of Ferric oxyhydroxide resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB15598",
                        "description": "Epinastine can cause a decrease in the absorption of Ferric maltol resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00230",
                        "description": "The therapeutic efficacy of Epinastine can be increased when used in combination with Pregabalin"
                    },
                    {
                        "drugbank-id": "DB08881",
                        "description": "The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB11637",
                        "description": "Epinastine may increase the QTc prolonging activities of Delamanid"
                    },
                    {
                        "drugbank-id": "DB11642",
                        "description": "The therapeutic efficacy of Pitolisant can be decreased when used in combination with Epinastine"
                    },
                    {
                        "drugbank-id": "DB04948",
                        "description": "The therapeutic efficacy of Lofexidine can be increased when used in combination with Epinastine"
                    },
                    {
                        "drugbank-id": "DB01238",
                        "description": "The metabolism of Aripiprazole can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB14185",
                        "description": "The metabolism of Aripiprazole lauroxil can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00358",
                        "description": "The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00187",
                        "description": "The risk or severity of QTc prolongation can be increased when Esmolol is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00188",
                        "description": "The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00674",
                        "description": "The risk or severity of QTc prolongation can be increased when Galantamine is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00983",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Formoterol"
                    },
                    {
                        "drugbank-id": "DB01071",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Mequitazine"
                    },
                    {
                        "drugbank-id": "DB01166",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Cilostazol"
                    },
                    {
                        "drugbank-id": "DB01228",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Encainide"
                    },
                    {
                        "drugbank-id": "DB01274",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Arformoterol"
                    },
                    {
                        "drugbank-id": "DB04846",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Celiprolol"
                    },
                    {
                        "drugbank-id": "DB08808",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB11614",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Rupatadine"
                    },
                    {
                        "drugbank-id": "DB11770",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Talinolol"
                    },
                    {
                        "drugbank-id": "DB11785",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Anisodamine"
                    },
                    {
                        "drugbank-id": "DB00104",
                        "description": "The risk or severity of QTc prolongation can be increased when Octreotide is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00107",
                        "description": "The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00196",
                        "description": "The risk or severity of QTc prolongation can be increased when Fluconazole is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00270",
                        "description": "The risk or severity of QTc prolongation can be increased when Isradipine is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00346",
                        "description": "The risk or severity of QTc prolongation can be increased when Alfuzosin is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00374",
                        "description": "The risk or severity of QTc prolongation can be increased when Treprostinil is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00390",
                        "description": "The risk or severity of QTc prolongation can be increased when Digoxin is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00467",
                        "description": "The risk or severity of QTc prolongation can be increased when Enoxacin is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00487",
                        "description": "The risk or severity of QTc prolongation can be increased when Pefloxacin is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00529",
                        "description": "The risk or severity of QTc prolongation can be increased when Foscarnet is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00613",
                        "description": "The risk or severity of QTc prolongation can be increased when Amodiaquine is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00678",
                        "description": "The risk or severity of QTc prolongation can be increased when Losartan is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00691",
                        "description": "The risk or severity of QTc prolongation can be increased when Moexipril is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00710",
                        "description": "The risk or severity of QTc prolongation can be increased when Ibandronate is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00719",
                        "description": "The risk or severity of QTc prolongation can be increased when Azatadine is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00808",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Indapamide"
                    },
                    {
                        "drugbank-id": "DB00817",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Rosoxacin"
                    },
                    {
                        "drugbank-id": "DB00822",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Disulfiram"
                    },
                    {
                        "drugbank-id": "DB00825",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Levomenthol"
                    },
                    {
                        "drugbank-id": "DB00845",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Clofazimine"
                    },
                    {
                        "drugbank-id": "DB00862",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Vardenafil"
                    },
                    {
                        "drugbank-id": "DB00864",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Tacrolimus"
                    },
                    {
                        "drugbank-id": "DB00871",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Terbutaline"
                    },
                    {
                        "drugbank-id": "DB00915",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Amantadine"
                    },
                    {
                        "drugbank-id": "DB00916",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Metronidazole"
                    },
                    {
                        "drugbank-id": "DB00920",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Ketotifen"
                    },
                    {
                        "drugbank-id": "DB00927",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Famotidine"
                    },
                    {
                        "drugbank-id": "DB00938",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Salmeterol"
                    },
                    {
                        "drugbank-id": "DB00999",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Hydrochlorothiazide"
                    },
                    {
                        "drugbank-id": "DB01001",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Salbutamol"
                    },
                    {
                        "drugbank-id": "DB01015",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Sulfamethoxazole"
                    },
                    {
                        "drugbank-id": "DB01044",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Gatifloxacin"
                    },
                    {
                        "drugbank-id": "DB01054",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Nitrendipine"
                    },
                    {
                        "drugbank-id": "DB01059",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Norfloxacin"
                    },
                    {
                        "drugbank-id": "DB01106",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Levocabastine"
                    },
                    {
                        "drugbank-id": "DB01158",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB01259",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01263",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01268",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Sunitinib"
                    },
                    {
                        "drugbank-id": "DB01396",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Digitoxin"
                    },
                    {
                        "drugbank-id": "DB01426",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB01601",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Lopinavir"
                    },
                    {
                        "drugbank-id": "DB01620",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Pheniramine"
                    },
                    {
                        "drugbank-id": "DB02546",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Vorinostat"
                    },
                    {
                        "drugbank-id": "DB04576",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Fleroxacin"
                    },
                    {
                        "drugbank-id": "DB04695",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Farnesyl thiopyrophosphate"
                    },
                    {
                        "drugbank-id": "DB05039",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB05465",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Tandutinib"
                    },
                    {
                        "drugbank-id": "DB06468",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Cariporide"
                    },
                    {
                        "drugbank-id": "DB06663",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Pasireotide"
                    },
                    {
                        "drugbank-id": "DB06699",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Degarelix"
                    },
                    {
                        "drugbank-id": "DB06719",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Buserelin"
                    },
                    {
                        "drugbank-id": "DB06788",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Histrelin"
                    },
                    {
                        "drugbank-id": "DB06825",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Triptorelin"
                    },
                    {
                        "drugbank-id": "DB07780",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Farnesyl diphosphate"
                    },
                    {
                        "drugbank-id": "DB07841",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Geranylgeranyl diphosphate"
                    },
                    {
                        "drugbank-id": "DB08871",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Eribulin"
                    },
                    {
                        "drugbank-id": "DB08936",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Chlorcyclizine"
                    },
                    {
                        "drugbank-id": "DB08972",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Flumequine"
                    },
                    {
                        "drugbank-id": "DB09080",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Olodaterol"
                    },
                    {
                        "drugbank-id": "DB09082",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB09090",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Pinaverium"
                    },
                    {
                        "drugbank-id": "DB09229",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Aranidipine"
                    },
                    {
                        "drugbank-id": "DB09235",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Efonidipine"
                    },
                    {
                        "drugbank-id": "DB09236",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Lacidipine"
                    },
                    {
                        "drugbank-id": "DB09239",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Niguldipine"
                    },
                    {
                        "drugbank-id": "DB09488",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB11390",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Coumaphos"
                    },
                    {
                        "drugbank-id": "DB11397",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Dichlorvos"
                    },
                    {
                        "drugbank-id": "DB11408",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Famphur"
                    },
                    {
                        "drugbank-id": "DB11412",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Fenthion"
                    },
                    {
                        "drugbank-id": "DB11443",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Orbifloxacin"
                    },
                    {
                        "drugbank-id": "DB11448",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Phosmet"
                    },
                    {
                        "drugbank-id": "DB11491",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Sarafloxacin"
                    },
                    {
                        "drugbank-id": "DB11511",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Difloxacin"
                    },
                    {
                        "drugbank-id": "DB11591",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Bilastine"
                    },
                    {
                        "drugbank-id": "DB11742",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Ebastine"
                    },
                    {
                        "drugbank-id": "DB11774",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Pazufloxacin"
                    },
                    {
                        "drugbank-id": "DB11796",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB11891",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with CUDC 907"
                    },
                    {
                        "drugbank-id": "DB11892",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Prulifloxacin"
                    },
                    {
                        "drugbank-id": "DB11943",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Delafloxacin"
                    },
                    {
                        "drugbank-id": "DB12231",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Temefos"
                    },
                    {
                        "drugbank-id": "DB12645",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Givinostat"
                    },
                    {
                        "drugbank-id": "DB12712",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Pilsicainide"
                    },
                    {
                        "drugbank-id": "DB12766",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Cicletanine"
                    },
                    {
                        "drugbank-id": "DB12923",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Gallopamil"
                    },
                    {
                        "drugbank-id": "DB13358",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Cibenzoline"
                    },
                    {
                        "drugbank-id": "DB13488",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Bencyclane"
                    },
                    {
                        "drugbank-id": "DB13555",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Prajmaline"
                    },
                    {
                        "drugbank-id": "DB13627",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Oxolinic acid"
                    },
                    {
                        "drugbank-id": "DB13651",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Lorajmine"
                    },
                    {
                        "drugbank-id": "DB13691",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Acetyldigoxin"
                    },
                    {
                        "drugbank-id": "DB13744",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Piromidic acid"
                    },
                    {
                        "drugbank-id": "DB13766",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Lidoflazine"
                    },
                    {
                        "drugbank-id": "DB13772",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Rufloxacin"
                    },
                    {
                        "drugbank-id": "DB13823",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Pipemidic acid"
                    },
                    {
                        "drugbank-id": "DB14713",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Inotersen"
                    },
                    {
                        "drugbank-id": "DB11853",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB09046",
                        "description": "The metabolism of Epinastine can be increased when combined with Metreleptin"
                    },
                    {
                        "drugbank-id": "DB00763",
                        "description": "The metabolism of Epinastine can be decreased when combined with Methimazole"
                    },
                    {
                        "drugbank-id": "DB00208",
                        "description": "The metabolism of Epinastine can be decreased when combined with Ticlopidine"
                    },
                    {
                        "drugbank-id": "DB00481",
                        "description": "The metabolism of Epinastine can be decreased when combined with Raloxifene"
                    },
                    {
                        "drugbank-id": "DB01043",
                        "description": "The metabolism of Epinastine can be decreased when combined with Memantine"
                    },
                    {
                        "drugbank-id": "DB00398",
                        "description": "The metabolism of Epinastine can be decreased when combined with Sorafenib"
                    },
                    {
                        "drugbank-id": "DB00758",
                        "description": "The metabolism of Epinastine can be decreased when combined with Clopidogrel"
                    },
                    {
                        "drugbank-id": "DB04572",
                        "description": "The metabolism of Epinastine can be decreased when combined with Thiotepa"
                    },
                    {
                        "drugbank-id": "DB13941",
                        "description": "The metabolism of Epinastine can be decreased when combined with Piperaquine"
                    },
                    {
                        "drugbank-id": "DB00238",
                        "description": "The metabolism of Epinastine can be increased when combined with Nevirapine"
                    },
                    {
                        "drugbank-id": "DB00252",
                        "description": "The metabolism of Epinastine can be increased when combined with Phenytoin"
                    },
                    {
                        "drugbank-id": "DB01174",
                        "description": "The metabolism of Phenobarbital can be increased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB01320",
                        "description": "The metabolism of Fosphenytoin can be increased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00615",
                        "description": "The metabolism of Epinastine can be increased when combined with Rifabutin"
                    },
                    {
                        "drugbank-id": "DB00661",
                        "description": "The metabolism of Epinastine can be decreased when combined with Verapamil"
                    },
                    {
                        "drugbank-id": "DB04938",
                        "description": "The metabolism of Epinastine can be decreased when combined with Ospemifene"
                    },
                    {
                        "drugbank-id": "DB11837",
                        "description": "The metabolism of Epinastine can be decreased when combined with Osilodrostat"
                    },
                    {
                        "drugbank-id": "DB00184",
                        "description": "The metabolism of Epinastine can be decreased when combined with Nicotine"
                    },
                    {
                        "drugbank-id": "DB00379",
                        "description": "The metabolism of Epinastine can be decreased when combined with Mexiletine"
                    },
                    {
                        "drugbank-id": "DB00568",
                        "description": "The metabolism of Epinastine can be decreased when combined with Cinnarizine"
                    },
                    {
                        "drugbank-id": "DB00586",
                        "description": "The metabolism of Epinastine can be decreased when combined with Diclofenac"
                    },
                    {
                        "drugbank-id": "DB00755",
                        "description": "The metabolism of Tretinoin can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00762",
                        "description": "The metabolism of Irinotecan can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00836",
                        "description": "The metabolism of Loperamide can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB01184",
                        "description": "The metabolism of Domperidone can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB01435",
                        "description": "The metabolism of Antipyrine can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB04975",
                        "description": "The metabolism of Banoxantrone can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB06176",
                        "description": "The metabolism of Romidepsin can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB06209",
                        "description": "The metabolism of Prasugrel can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB06697",
                        "description": "The metabolism of Artemether can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB06710",
                        "description": "The metabolism of Methyltestosterone can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB06739",
                        "description": "The metabolism of Seratrodast can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB11613",
                        "description": "The metabolism of Velpatasvir can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB11757",
                        "description": "The metabolism of Istradefylline can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB13132",
                        "description": "The metabolism of Artemisinin can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB13943",
                        "description": "The metabolism of Testosterone cypionate can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB13944",
                        "description": "The metabolism of Testosterone enanthate can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB13946",
                        "description": "The metabolism of Testosterone undecanoate can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB14975",
                        "description": "The metabolism of Voxelotor can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00655",
                        "description": "The metabolism of Epinastine can be decreased when combined with Estrone"
                    },
                    {
                        "drugbank-id": "DB00957",
                        "description": "The metabolism of Norgestimate can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB04930",
                        "description": "The metabolism of Permethrin can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00675",
                        "description": "The metabolism of Epinastine can be decreased when combined with Tamoxifen"
                    },
                    {
                        "drugbank-id": "DB00531",
                        "description": "The metabolism of Epinastine can be decreased when combined with Cyclophosphamide"
                    },
                    {
                        "drugbank-id": "DB01181",
                        "description": "The metabolism of Ifosfamide can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB13874",
                        "description": "The metabolism of Enasidenib can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB15035",
                        "description": "The metabolism of Zanubrutinib can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB11633",
                        "description": "The metabolism of Epinastine can be decreased when combined with Isavuconazole"
                    },
                    {
                        "drugbank-id": "DB00281",
                        "description": "The metabolism of Epinastine can be decreased when combined with Lidocaine"
                    },
                    {
                        "drugbank-id": "DB00412",
                        "description": "The metabolism of Epinastine can be decreased when combined with Rosiglitazone"
                    },
                    {
                        "drugbank-id": "DB00439",
                        "description": "The metabolism of Epinastine can be decreased when combined with Cerivastatin"
                    },
                    {
                        "drugbank-id": "DB00528",
                        "description": "The metabolism of Epinastine can be decreased when combined with Lercanidipine"
                    },
                    {
                        "drugbank-id": "DB00598",
                        "description": "The metabolism of Epinastine can be decreased when combined with Labetalol"
                    },
                    {
                        "drugbank-id": "DB00627",
                        "description": "The metabolism of Epinastine can be decreased when combined with Niacin"
                    },
                    {
                        "drugbank-id": "DB00792",
                        "description": "The metabolism of Epinastine can be decreased when combined with Tripelennamine"
                    },
                    {
                        "drugbank-id": "DB00834",
                        "description": "The metabolism of Epinastine can be decreased when combined with Mifepristone"
                    },
                    {
                        "drugbank-id": "DB00863",
                        "description": "The metabolism of Epinastine can be decreased when combined with Ranitidine"
                    },
                    {
                        "drugbank-id": "DB00997",
                        "description": "The metabolism of Epinastine can be decreased when combined with Doxorubicin"
                    },
                    {
                        "drugbank-id": "DB01005",
                        "description": "The metabolism of Epinastine can be decreased when combined with Hydroxyurea"
                    },
                    {
                        "drugbank-id": "DB01023",
                        "description": "The metabolism of Epinastine can be decreased when combined with Felodipine"
                    },
                    {
                        "drugbank-id": "DB01093",
                        "description": "The metabolism of Epinastine can be decreased when combined with Dimethyl sulfoxide"
                    },
                    {
                        "drugbank-id": "DB01096",
                        "description": "The metabolism of Epinastine can be decreased when combined with Oxamniquine"
                    },
                    {
                        "drugbank-id": "DB01110",
                        "description": "The metabolism of Epinastine can be decreased when combined with Miconazole"
                    },
                    {
                        "drugbank-id": "DB01115",
                        "description": "The metabolism of Epinastine can be decreased when combined with Nifedipine"
                    },
                    {
                        "drugbank-id": "DB01128",
                        "description": "The metabolism of Epinastine can be decreased when combined with Bicalutamide"
                    },
                    {
                        "drugbank-id": "DB01193",
                        "description": "The metabolism of Epinastine can be decreased when combined with Acebutolol"
                    },
                    {
                        "drugbank-id": "DB01244",
                        "description": "The metabolism of Epinastine can be decreased when combined with Bepridil"
                    },
                    {
                        "drugbank-id": "DB01388",
                        "description": "The metabolism of Epinastine can be decreased when combined with Mibefradil"
                    },
                    {
                        "drugbank-id": "DB01562",
                        "description": "The metabolism of Epinastine can be decreased when combined with 1 2 Phenylethyl 4 phenyl 4 acetoxypiperidine"
                    },
                    {
                        "drugbank-id": "DB01590",
                        "description": "The metabolism of Epinastine can be decreased when combined with Everolimus"
                    },
                    {
                        "drugbank-id": "DB01611",
                        "description": "The metabolism of Epinastine can be decreased when combined with Hydroxychloroquine"
                    },
                    {
                        "drugbank-id": "DB06217",
                        "description": "The metabolism of Epinastine can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB06370",
                        "description": "The metabolism of Epinastine can be decreased when combined with Indisulam"
                    },
                    {
                        "drugbank-id": "DB06412",
                        "description": "The metabolism of Epinastine can be decreased when combined with Oxymetholone"
                    },
                    {
                        "drugbank-id": "DB06727",
                        "description": "The metabolism of Epinastine can be decreased when combined with Sparteine"
                    },
                    {
                        "drugbank-id": "DB09039",
                        "description": "The metabolism of Epinastine can be decreased when combined with Eliglustat"
                    },
                    {
                        "drugbank-id": "DB09049",
                        "description": "The metabolism of Epinastine can be decreased when combined with Naloxegol"
                    },
                    {
                        "drugbank-id": "DB09078",
                        "description": "The metabolism of Epinastine can be decreased when combined with Lenvatinib"
                    },
                    {
                        "drugbank-id": "DB09555",
                        "description": "The metabolism of Epinastine can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB11638",
                        "description": "The metabolism of Epinastine can be decreased when combined with Artenimol"
                    },
                    {
                        "drugbank-id": "DB11753",
                        "description": "The metabolism of Epinastine can be decreased when combined with Rifamycin"
                    },
                    {
                        "drugbank-id": "DB11994",
                        "description": "The metabolism of Epinastine can be decreased when combined with Diacerein"
                    },
                    {
                        "drugbank-id": "DB12245",
                        "description": "The metabolism of Epinastine can be decreased when combined with Triclabendazole"
                    },
                    {
                        "drugbank-id": "DB12523",
                        "description": "The metabolism of Epinastine can be decreased when combined with Mizolastine"
                    },
                    {
                        "drugbank-id": "DB13139",
                        "description": "The metabolism of Epinastine can be decreased when combined with Levosalbutamol"
                    },
                    {
                        "drugbank-id": "DB13679",
                        "description": "The metabolism of Epinastine can be decreased when combined with Dexchlorpheniramine"
                    },
                    {
                        "drugbank-id": "DB13975",
                        "description": "The metabolism of Epinastine can be decreased when combined with Black cohosh"
                    },
                    {
                        "drugbank-id": "DB14009",
                        "description": "The metabolism of Epinastine can be decreased when combined with Medical Cannabis"
                    },
                    {
                        "drugbank-id": "DB14635",
                        "description": "The metabolism of Epinastine can be decreased when combined with Curcumin sulfate"
                    },
                    {
                        "drugbank-id": "DB12500",
                        "description": "The metabolism of Epinastine can be decreased when combined with Fedratinib"
                    },
                    {
                        "drugbank-id": "DB00022",
                        "description": "The metabolism of Epinastine can be decreased when combined with Peginterferon alfa 2b"
                    },
                    {
                        "drugbank-id": "DB00227",
                        "description": "The metabolism of Epinastine can be decreased when combined with Lovastatin"
                    },
                    {
                        "drugbank-id": "DB00338",
                        "description": "The metabolism of Epinastine can be decreased when combined with Omeprazole"
                    },
                    {
                        "drugbank-id": "DB00361",
                        "description": "The metabolism of Epinastine can be decreased when combined with Vinorelbine"
                    },
                    {
                        "drugbank-id": "DB00448",
                        "description": "The metabolism of Epinastine can be decreased when combined with Lansoprazole"
                    },
                    {
                        "drugbank-id": "DB00570",
                        "description": "The metabolism of Epinastine can be decreased when combined with Vinblastine"
                    },
                    {
                        "drugbank-id": "DB01129",
                        "description": "The metabolism of Epinastine can be decreased when combined with Rabeprazole"
                    },
                    {
                        "drugbank-id": "DB01131",
                        "description": "The metabolism of Epinastine can be decreased when combined with Proguanil"
                    },
                    {
                        "drugbank-id": "DB01191",
                        "description": "The metabolism of Epinastine can be decreased when combined with Dexfenfluramine"
                    },
                    {
                        "drugbank-id": "DB01628",
                        "description": "The metabolism of Epinastine can be decreased when combined with Etoricoxib"
                    },
                    {
                        "drugbank-id": "DB04911",
                        "description": "The metabolism of Epinastine can be decreased when combined with Oritavancin"
                    },
                    {
                        "drugbank-id": "DB06287",
                        "description": "The metabolism of Epinastine can be decreased when combined with Temsirolimus"
                    },
                    {
                        "drugbank-id": "DB09065",
                        "description": "The metabolism of Epinastine can be decreased when combined with Cobicistat"
                    },
                    {
                        "drugbank-id": "DB00185",
                        "description": "The metabolism of Epinastine can be decreased when combined with Cevimeline"
                    },
                    {
                        "drugbank-id": "DB00203",
                        "description": "The metabolism of Epinastine can be decreased when combined with Sildenafil"
                    },
                    {
                        "drugbank-id": "DB00297",
                        "description": "The metabolism of Epinastine can be decreased when combined with Bupivacaine"
                    },
                    {
                        "drugbank-id": "DB00316",
                        "description": "The metabolism of Epinastine can be decreased when combined with Acetaminophen"
                    },
                    {
                        "drugbank-id": "DB00335",
                        "description": "The metabolism of Epinastine can be decreased when combined with Atenolol"
                    },
                    {
                        "drugbank-id": "DB00396",
                        "description": "The metabolism of Epinastine can be decreased when combined with Progesterone"
                    },
                    {
                        "drugbank-id": "DB00490",
                        "description": "The metabolism of Epinastine can be decreased when combined with Buspirone"
                    },
                    {
                        "drugbank-id": "DB00590",
                        "description": "The metabolism of Epinastine can be decreased when combined with Doxazosin"
                    },
                    {
                        "drugbank-id": "DB00592",
                        "description": "The metabolism of Epinastine can be decreased when combined with Piperazine"
                    },
                    {
                        "drugbank-id": "DB00699",
                        "description": "The metabolism of Epinastine can be decreased when combined with Nicergoline"
                    },
                    {
                        "drugbank-id": "DB00706",
                        "description": "The metabolism of Epinastine can be decreased when combined with Tamsulosin"
                    },
                    {
                        "drugbank-id": "DB00731",
                        "description": "The metabolism of Epinastine can be decreased when combined with Nateglinide"
                    },
                    {
                        "drugbank-id": "DB00914",
                        "description": "The metabolism of Phenformin can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB01136",
                        "description": "The metabolism of Carvedilol can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB01177",
                        "description": "The metabolism of Idarubicin can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB01203",
                        "description": "The metabolism of Nadolol can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB01295",
                        "description": "The metabolism of Bevantolol can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB01297",
                        "description": "The metabolism of Practolol can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB01410",
                        "description": "The metabolism of Ciclesonide can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB01424",
                        "description": "The metabolism of Aminophenazone can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB01429",
                        "description": "The metabolism of Aprindine can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB03783",
                        "description": "The metabolism of Phenacetin can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB04840",
                        "description": "The metabolism of Debrisoquine can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB04861",
                        "description": "The metabolism of Nebivolol can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB04889",
                        "description": "The metabolism of Bicifadine can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB04905",
                        "description": "The metabolism of Tesmilifene can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB04920",
                        "description": "The metabolism of Clevidipine can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB06203",
                        "description": "The metabolism of Alogliptin can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB06292",
                        "description": "The metabolism of Dapagliflozin can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB06506",
                        "description": "The metabolism of Repinotan can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB06608",
                        "description": "The metabolism of Tafenoquine can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB06726",
                        "description": "The metabolism of Bufuralol can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB06735",
                        "description": "The metabolism of Enclomiphene can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB08807",
                        "description": "The metabolism of Bopindolol can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB09048",
                        "description": "The metabolism of Netupitant can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB09053",
                        "description": "The metabolism of Ibrutinib can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB09173",
                        "description": "The metabolism of Butyrfentanyl can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB09183",
                        "description": "The metabolism of Dasabuvir can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB09195",
                        "description": "The metabolism of Lorpiprazole can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB09204",
                        "description": "The metabolism of Arotinolol can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB09288",
                        "description": "The metabolism of Propacetamol can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB09351",
                        "description": "The metabolism of Levobetaxolol can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB11915",
                        "description": "The metabolism of Valbenazine can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB11979",
                        "description": "The metabolism of Elagolix can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB12212",
                        "description": "The metabolism of Landiolol can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB12752",
                        "description": "The metabolism of Bucindolol can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB13293",
                        "description": "The metabolism of Ipecac can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB13443",
                        "description": "The metabolism of Esatenolol can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB13508",
                        "description": "The metabolism of Cloranolol can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB13530",
                        "description": "The metabolism of Mepindolol can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB13757",
                        "description": "The metabolism of Epanolol can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB13775",
                        "description": "The metabolism of Tertatolol can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00543",
                        "description": "The metabolism of Amoxapine can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB11963",
                        "description": "The metabolism of Epinastine can be decreased when combined with Dacomitinib"
                    },
                    {
                        "drugbank-id": "DB00726",
                        "description": "The metabolism of Epinastine can be decreased when combined with Trimipramine"
                    },
                    {
                        "drugbank-id": "DB01100",
                        "description": "The metabolism of Pimozide can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB01242",
                        "description": "The metabolism of Clomipramine can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB01195",
                        "description": "The metabolism of Epinastine can be decreased when combined with Flecainide"
                    },
                    {
                        "drugbank-id": "DB00277",
                        "description": "The metabolism of Epinastine can be decreased when combined with Theophylline"
                    },
                    {
                        "drugbank-id": "DB00489",
                        "description": "The metabolism of Epinastine can be decreased when combined with Sotalol"
                    },
                    {
                        "drugbank-id": "DB00637",
                        "description": "The metabolism of Epinastine can be decreased when combined with Astemizole"
                    },
                    {
                        "drugbank-id": "DB01035",
                        "description": "The metabolism of Procainamide can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB05109",
                        "description": "The metabolism of Trabectedin can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB08901",
                        "description": "The metabolism of Ponatinib can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00435",
                        "description": "The metabolism of Epinastine can be decreased when combined with Nitric Oxide"
                    },
                    {
                        "drugbank-id": "DB00515",
                        "description": "The metabolism of Epinastine can be decreased when combined with Cisplatin"
                    },
                    {
                        "drugbank-id": "DB00582",
                        "description": "The metabolism of Epinastine can be decreased when combined with Voriconazole"
                    },
                    {
                        "drugbank-id": "DB00745",
                        "description": "The metabolism of Epinastine can be decreased when combined with Modafinil"
                    },
                    {
                        "drugbank-id": "DB00778",
                        "description": "The metabolism of Epinastine can be decreased when combined with Roxithromycin"
                    },
                    {
                        "drugbank-id": "DB01394",
                        "description": "The metabolism of Epinastine can be decreased when combined with Colchicine"
                    },
                    {
                        "drugbank-id": "DB08896",
                        "description": "The metabolism of Epinastine can be decreased when combined with Regorafenib"
                    },
                    {
                        "drugbank-id": "DB08899",
                        "description": "The metabolism of Epinastine can be decreased when combined with Enzalutamide"
                    },
                    {
                        "drugbank-id": "DB00641",
                        "description": "The metabolism of Epinastine can be increased when combined with Simvastatin"
                    },
                    {
                        "drugbank-id": "DB01095",
                        "description": "The metabolism of Fluvastatin can be increased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB12070",
                        "description": "The metabolism of Letermovir can be increased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00197",
                        "description": "The metabolism of Epinastine can be increased when combined with Troglitazone"
                    },
                    {
                        "drugbank-id": "DB00443",
                        "description": "The metabolism of Epinastine can be increased when combined with Betamethasone"
                    },
                    {
                        "drugbank-id": "DB00741",
                        "description": "The metabolism of Epinastine can be increased when combined with Hydrocortisone"
                    },
                    {
                        "drugbank-id": "DB01138",
                        "description": "The metabolism of Epinastine can be increased when combined with Sulfinpyrazone"
                    },
                    {
                        "drugbank-id": "DB01201",
                        "description": "The metabolism of Epinastine can be increased when combined with Rifapentine"
                    },
                    {
                        "drugbank-id": "DB01234",
                        "description": "The metabolism of Epinastine can be increased when combined with Dexamethasone"
                    },
                    {
                        "drugbank-id": "DB04817",
                        "description": "The metabolism of Epinastine can be increased when combined with Metamizole"
                    },
                    {
                        "drugbank-id": "DB06413",
                        "description": "The metabolism of Epinastine can be increased when combined with Armodafinil"
                    },
                    {
                        "drugbank-id": "DB09074",
                        "description": "The metabolism of Epinastine can be increased when combined with Olaparib"
                    },
                    {
                        "drugbank-id": "DB09280",
                        "description": "The metabolism of Epinastine can be increased when combined with Lumacaftor"
                    },
                    {
                        "drugbank-id": "DB12130",
                        "description": "The metabolism of Epinastine can be increased when combined with Lorlatinib"
                    },
                    {
                        "drugbank-id": "DB14631",
                        "description": "The metabolism of Epinastine can be increased when combined with Prednisolone phosphate"
                    },
                    {
                        "drugbank-id": "DB12015",
                        "description": "The metabolism of Epinastine can be increased when combined with Alpelisib"
                    },
                    {
                        "drugbank-id": "DB09061",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB14011",
                        "description": "The risk or severity of adverse effects can be increased when Nabiximols is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB05077",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB06155",
                        "description": "The risk or severity of adverse effects can be increased when Rimonabant is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB06624",
                        "description": "The risk or severity of adverse effects can be increased when Taranabant is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB11903",
                        "description": "The risk or severity of adverse effects can be increased when GW842166 is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB12193",
                        "description": "The risk or severity of adverse effects can be increased when Ajulemic acid is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB12649",
                        "description": "The risk or severity of adverse effects can be increased when Ibipinabant is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB13070",
                        "description": "The risk or severity of adverse effects can be increased when Surinabant is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB13950",
                        "description": "The risk or severity of adverse effects can be increased when WIN 55212 2 is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB14043",
                        "description": "The risk or severity of adverse effects can be increased when Palmidrol is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB14737",
                        "description": "The risk or severity of adverse effects can be increased when Cannabinol is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB04794",
                        "description": "Epinastine can cause a decrease in the absorption of Bifonazole resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB06395",
                        "description": "Epinastine can cause a decrease in the absorption of Abafungin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB06440",
                        "description": "Epinastine can cause a decrease in the absorption of Ravuconazole resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB06636",
                        "description": "Epinastine can cause a decrease in the absorption of Isavuconazonium resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB12073",
                        "description": "Epinastine can cause a decrease in the absorption of Albaconazole resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB12141",
                        "description": "The therapeutic efficacy of Epinastine can be decreased when used in combination with Gilteritinib"
                    },
                    {
                        "drugbank-id": "DB00005",
                        "description": "The metabolism of Epinastine can be increased when combined with Etanercept"
                    },
                    {
                        "drugbank-id": "DB00026",
                        "description": "The metabolism of Epinastine can be increased when combined with Anakinra"
                    },
                    {
                        "drugbank-id": "DB00051",
                        "description": "The metabolism of Epinastine can be increased when combined with Adalimumab"
                    },
                    {
                        "drugbank-id": "DB00065",
                        "description": "The metabolism of Epinastine can be increased when combined with Infliximab"
                    },
                    {
                        "drugbank-id": "DB01281",
                        "description": "The metabolism of Epinastine can be increased when combined with Abatacept"
                    },
                    {
                        "drugbank-id": "DB04956",
                        "description": "The metabolism of Epinastine can be increased when combined with Afelimomab"
                    },
                    {
                        "drugbank-id": "DB05676",
                        "description": "The metabolism of Epinastine can be increased when combined with Apremilast"
                    },
                    {
                        "drugbank-id": "DB06168",
                        "description": "The metabolism of Epinastine can be increased when combined with Canakinumab"
                    },
                    {
                        "drugbank-id": "DB06273",
                        "description": "The metabolism of Epinastine can be increased when combined with Tocilizumab"
                    },
                    {
                        "drugbank-id": "DB06372",
                        "description": "The metabolism of Epinastine can be increased when combined with Rilonacept"
                    },
                    {
                        "drugbank-id": "DB06674",
                        "description": "The metabolism of Epinastine can be increased when combined with Golimumab"
                    },
                    {
                        "drugbank-id": "DB08904",
                        "description": "The metabolism of Epinastine can be increased when combined with Certolizumab pegol"
                    },
                    {
                        "drugbank-id": "DB09029",
                        "description": "The metabolism of Epinastine can be increased when combined with Secukinumab"
                    },
                    {
                        "drugbank-id": "DB09036",
                        "description": "The metabolism of Epinastine can be increased when combined with Siltuximab"
                    },
                    {
                        "drugbank-id": "DB14724",
                        "description": "The metabolism of Epinastine can be increased when combined with Emapalumab"
                    },
                    {
                        "drugbank-id": "DB00321",
                        "description": "The metabolism of Epinastine can be decreased when combined with Amitriptyline"
                    },
                    {
                        "drugbank-id": "DB11823",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Esketamine"
                    },
                    {
                        "drugbank-id": "DB00395",
                        "description": "The risk or severity of adverse effects can be increased when Carisoprodol is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00373",
                        "description": "The metabolism of Timolol can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00402",
                        "description": "The risk or severity of CNS depression can be increased when Epinastine is combined with Eszopiclone"
                    },
                    {
                        "drugbank-id": "DB00575",
                        "description": "The risk or severity of sedation can be increased when Clonidine is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00656",
                        "description": "The risk or severity of QTc prolongation can be increased when Trazodone is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB11986",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Entrectinib"
                    },
                    {
                        "drugbank-id": "DB12825",
                        "description": "Lefamulin may increase the QTc prolonging activities of Epinastine"
                    },
                    {
                        "drugbank-id": "DB00924",
                        "description": "The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB01233",
                        "description": "The risk or severity of sedation can be increased when Metoclopramide is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB01175",
                        "description": "The serum concentration of Epinastine can be increased when it is combined with Escitalopram"
                    },
                    {
                        "drugbank-id": "DB04855",
                        "description": "The metabolism of Epinastine can be decreased when combined with Dronedarone"
                    },
                    {
                        "drugbank-id": "DB11732",
                        "description": "The risk or severity of adverse effects can be increased when Lasmiditan is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB15066",
                        "description": "The serum concentration of Epinastine can be increased when it is combined with Givosiran"
                    },
                    {
                        "drugbank-id": "DB06119",
                        "description": "The serum concentration of Epinastine can be decreased when it is combined with Cenobamate"
                    },
                    {
                        "drugbank-id": "DB01222",
                        "description": "Epinastine can cause a decrease in the absorption of Budesonide resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11951",
                        "description": "The serum concentration of Epinastine can be decreased when it is combined with Lemborexant"
                    },
                    {
                        "drugbank-id": "DB00243",
                        "description": "The serum concentration of Epinastine can be increased when it is combined with Ranolazine"
                    },
                    {
                        "drugbank-id": "DB00557",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Hydroxyzine"
                    },
                    {
                        "drugbank-id": "DB00193",
                        "description": "The risk or severity of CNS depression can be increased when Epinastine is combined with Tramadol"
                    },
                    {
                        "drugbank-id": "DB00246",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Ziprasidone"
                    },
                    {
                        "drugbank-id": "DB00540",
                        "description": "The serum concentration of Nortriptyline can be increased when it is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00503",
                        "description": "The serum concentration of Epinastine can be increased when it is combined with Ritonavir"
                    },
                    {
                        "drugbank-id": "DB00502",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Haloperidol"
                    },
                    {
                        "drugbank-id": "DB11652",
                        "description": "The metabolism of Tucatinib can be decreased when combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB15685",
                        "description": "The serum concentration of Selpercatinib can be decreased when it is combined with Epinastine"
                    },
                    {
                        "drugbank-id": "DB00472",
                        "description": "The serum concentration of Epinastine can be increased when it is combined with Fluoxetine"
                    },
                    {
                        "drugbank-id": "DB11932",
                        "description": "The serum concentration of Epinastine can be increased when it is combined with Abametapir"
                    },
                    {
                        "drugbank-id": "DB14881",
                        "description": "The risk or severity of hypotension sedation death somnolence and respiratory depression can be increased when Epinastine is combined with Oliceridine"
                    },
                    {
                        "drugbank-id": "DB15762",
                        "description": "The serum concentration of Epinastine can be decreased when it is combined with Satralizumab"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}